Melanocytic naevi of trunk

CD2_BENIGN_MELANOCYTIC_TRUNK_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D22.5& Hospital discharge: ICD-9 — 2165A Cause of death: ICD-10 — D22.5& Cause of death: ICD-9 — 2165A 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D22
Name in latin: Naevus melanocyticus (cutis) trunci

NAME	CD2_BENIGN_MELANOCYTIC_TRUNK_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D225
HD_ICD_9	2165A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D225
COD_ICD_9	2165A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Melanocytic naevi of trunk based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Melanocytic naevi of trunk

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	4886	2900	1986
Unadjusted period prevalence (%)	0.94	0.99	0.88
Median age at first event (years)	51.66	45.48	60.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
4300: Matched controls
43000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

323.0

335

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

309.2

323.0

443

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

13.1

323.0

1257

1311

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1384.3

323.0

4130

741

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

44.2

323.0

1915

766

PJA12

NOMESCO Finland

Sentinel node biopsy

995.2

323.0

447

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

14.5

323.0

759

625

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

10.0

304.3

649

753

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

445.9

295.8

293

L57.0

ICD-10 Finland

Actinic keratosis

8.2

286.4

688

972

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

2739.7

280.0

268

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

9.8

269.4

577

668

130

Kela drug reimbursment

Malignant tumour

+∞

246.2

234

115

Kela drug reimbursment

Breast cancer

+∞

232.4

221

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

13.4

220.2

399

326

C61

ICD-10 Finland

Malignant neoplasm of prostate

211.6

214.5

221

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1987.3

207.8

200

TQW99

NOMESCO Finland

Other minor procedure on skin

10.1

204.6

427

463

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

197.4

188

XQ845

NOMESCO Finland

Dermatoscopy

31.5

196.3

264

2165A

ICD-9 Finland

Benign neoplasm of skin, Skin of trunk, except scrotum[VARTALON IHON BEN KASVAIN,NAEVUS PIGMENTOSUS]

+∞

184.7

176

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

14.7

178.5

309

225

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

14.7

174.3

302

220

R23.8

ICD-10 Finland

Other and unspecified skin changes

3.6

173.9

918

3017

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

+∞

166.7

159

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

165.7

158

H02AB02

ATC

dexamethasone; systemic

17.0

165.0

269

168

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

1707.1

164.6

159

L82

ICD-10 Finland

Seborrhoeic keratosis

3.5

161.4

891

3013

XQ848

NOMESCO Finland

Dermatological photography

11.8

161.0

308

279

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

155.1

148

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

14.4

153.9

268

197

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

14.0

152.4

269

204

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

150.9

144

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

117.9

147.1

159

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

27.4

139.3

194

A04AA02

ATC

granisetron; systemic, transdermal

85.2

139.2

156

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

130.9

125

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

126.7

121

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

126.7

121

S18

ICPC

Laceration/cut

2.2

117.1

1800

10690

ZZR00

NOMESCO Finland

Flap of skin

25.8

111.1

157

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

107.7

103

JN4BD

NOMESCO Finland

Extensive body CT

5.2

107.1

357

740

D03.5

ICD-10 Finland

Melanoma in situ of trunk

92.5

105.6

117

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

161.1

104.7

110

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

355.6

104.6

105

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

11.9

104.1

197

173

L02BA01

ATC

tamoxifen; oral

66.7

101.1

117

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

12.6

100.0

184

152

116

Kela drug reimbursment

Prostate cancer

+∞

98.3

HAC20

NOMESCO Finland

Total mastectomy

206.7

97.8

101

ZXC50

NOMESCO Finland

Cryotherapy

10.0

96.4

199

207

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

320.5

94.3

WF002

NOMESCO Finland

Radical radiotherapy

48.7

93.6

114

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

12.0

92.2

173

149

127

Kela drug reimbursment

Transplant complication

11.7

92.1

175

155

L03AA13

ATC

pegfilgrastim; parenteral

457.0

90.5

HAB40

NOMESCO Finland

Wedge excision of mammary gland

29.4

90.4

123

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

451.8

89.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

87.8

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

17.9

86.3

137

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

134.2

86.3

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

85.7

WF003

NOMESCO Finland

Adjuvant radiotherapy

179.5

84.5

HA1AA

NOMESCO Finland

X-ray mammography

6.0

83.1

240

417

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.9

82.8

245

439

WF049

NOMESCO Finland

Radiotherapy of metastasis

+∞

79.4

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

123.8

79.2

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

394.4

78.1

C43.53

ICD-10 Finland

Malignant melanoma of the torso nodular

+∞

77.3

A03FA01

ATC

metoclopramide; systemic, rectal

2.6

76.8

645

2754

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

34.9

76.0

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

378.8

75.0

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

193.3

73.4

SPAT1153

SPAT

Removal of sutures

1.9

72.5

1299

7812

ZX090

NOMESCO Finland

Other technic of radiotherapy

130.6

72.1

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

6.5

71.2

194

312

C43.62

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type

+∞

71.0

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

25.5

70.9

100

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

240.5

69.5

C50.99

ICD-10 Finland

Breast, unspecified

347.6

68.7

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

67.1

1068

6102

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.9

66.3

1243

7550

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

92.8

66.1

9733

FHL

Excision of skin change in operating room or anesthesia

9.2

66.1

142

159

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

63.7

Z94.0

ICD-10 Finland

Kidney transplant status

10.4

63.6

128

127

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

627.0

63.0

A04AA55

ATC

palonosetron, combinations; systemic

+∞

62.6

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

+∞

61.6

8743/3-C44.9

ICD-O-3

Low cumulative sun damage melanoma of skin, NOS

+∞

60.5

8720/3-C44.6

ICD-O-3

Malignant melanoma, NOS, of skin of upper limb and shoulder

+∞

60.5

L01BC06

ATC

capecitabine; oral

+∞

60.5

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

16.1

59.8

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

206.1

59.2

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

6.2

58.5

163

270

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

57.4

S82

ICPC

Naevus/mole

2.3

57.1

573

2656

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

7.3

56.5

140

197

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

56.4

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

55.3

ZXC15

NOMESCO Finland

Use of photodynamic technique

22.6

54.9

L04AA06

ATC

mycophenolic acid; systemic

6.5

54.6

147

233

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

117.5

53.9

8720/3-C44.7

ICD-O-3

Malignant melanoma, NOS, of skin of lower limb and hip

+∞

53.2

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

52.2

JN4AD

NOMESCO Finland

Body CT examination

4.4

52.1

198

467

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

51.9

1544

10685

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

26.1

51.6

L04AD01

ATC

ciclosporin; systemic

5.8

51.6

152

271

C43.5

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of trunk

513.8

51.5

R4110

NOMESCO Finland

Physiotherapy

1.8

51.2

1001

6073

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

51.1

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

51.1

S77

ICPC

Malignant neoplasm of skin

73.6

51.1

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

136.6

50.9

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

50.1

L02BG04

ATC

letrozole; oral

4.9

49.6

168

352

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

493.3

49.5

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

+∞

49.0

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

49.0

ZQZ00

NOMESCO Finland

Treatment of several skin areas

31.4

49.0

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

483.0

48.4

L02BB03

ATC

bicalutamide; oral

+∞

48.0

C50

ICD-10 Finland

Malignant neoplasm of breast

472.8

47.4

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

14.8

47.3

XX3DW

NOMESCO Finland

Time consuming IT work

3.3

47.2

248

772

NK6AN

NOMESCO Finland

Total body bone isotope imaging

34.3

47.0

C43

ICD-10 Finland

Malignant melanoma of skin

165.1

46.9

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

165.1

46.9

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

32.5

46.4

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

45.9

ZXA05

NOMESCO Finland

Left side

1.8

45.1

930

5704

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

44.1

1035

6609

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

42.8

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

42.8

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

4.9

42.8

144

300

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.3

42.4

134

260

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.9

42.4

775

4552

C43.69

ICD-10 Finland

Malignant melanoma of the upper extremity including shoulder other or unspecified histology

421.6

42.2

D06BB10

ATC

imiquimod; topical

3.2

41.9

229

734

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

9.3

41.8

A04AA01

ATC

ondansetron; systemic, rectal

4.0

41.1

171

439

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

67.7

41.1

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

77.6

40.9

ZXC20

NOMESCO Finland

Use of chemical agents

7.5

40.7

133

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

40.7

D22

ICD-10 Finland

Melanocytic naevi

3.0

40.4

245

845

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

59.3

40.3

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

4.9

40.1

135

281

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

24.0

40.1

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

66.3

40.1

ZXA00

NOMESCO Finland

Right side

1.7

40.1

975

6266

Z51.5

ICD-10 Finland

Palliative care

5.8

40.0

116

203

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

39.6

180

Kela drug reimbursment

Interferon alfa

+∞

39.6

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

39.6

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

39.6

137

Kela drug reimbursment

Uraemia requiring dialysis

9.4

39.5

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.2

39.3

213

679

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

6.2

39.3

108

177

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

9.4

39.1

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

201.7

38.9

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

38.6

8743/3-C44.5

ICD-O-3

Low cumulative sun damage melanoma of skin of trunk

+∞

38.6

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

38.6

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

38.6

L03AA02

ATC

filgrastim; parenteral

30.3

38.2

WX402

NOMESCO Finland

General anaesthesia

1.9

38.1

583

3200

ZX120

NOMESCO Finland

Intravenous

2.5

37.9

328

1397

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

196.6

37.8

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

37.3

37.8

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

4.5

37.7

138

314

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

4.5

37.4

137

312

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

37.3

496

2578

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

9.6

36.9

X76

ICPC

Malignant neoplasm breast female

191.6

36.8

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

36.5

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

6.0

36.3

103

176

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

12.7

36.2

A04AD12

ATC

aprepitant; systemic

60.5

36.2

J01DB01

ATC

cefalexin; oral

1.6

36.1

3339

29461

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

15.7

36.0

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

127.7

35.7

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

35.5

TQW20

NOMESCO Finland

Tatoe

43.4

35.0

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.9

34.8

224

803

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

37.0

34.6

L04AA01

ATC

[U] ciclosporin; systemic

5.6

34.5

103

188

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

34.4

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

34.4

A11CC03

ATC

alfacalcidol; systemic

4.5

34.2

126

289

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

23.1

33.5

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

33.4

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

33.4

C43.99

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin other or unspecified histology

+∞

33.4

ZX080

NOMESCO Finland

Image guided radiotherapy

329.5

32.9

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.7

32.6

239

929

A12AA04

ATC

calcium carbonate; oral

5.6

32.5

177

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

32.3

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

72.7

31.9

Y77

ICPC

Malignant neoplasm prostate

72.7

31.9

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

166.2

31.7

Z31.5

ICD-10 Finland

Genetic counselling

2.9

31.4

201

717

B01AB05

ATC

enoxaparin; parenteral

1.6

31.3

952

6440

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

31.3

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.5

30.6

DHB00

NOMESCO Finland

Excision of lesion of external nose

17.3

30.5

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

11.1

30.4

E0000UV

ATC

1.5

30.4

1514

11490

TQW80

NOMESCO Finland

Local dermatologic skincare

3.7

30.3

135

370

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

30.2

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

30.2

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

304.4

29.8

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

11.3

29.7

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

156.0

29.7

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

29.2

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

29.2

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

29.2

L02BG03

ATC

anastrozole; oral

57.1

29.1

JN4CD

NOMESCO Finland

Very extensive body CT

5.0

29.1

193

QBA99

NOMESCO Finland

Other local destruction of skin of trunk

11.1

29.0

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

151.0

28.7

S29

ICPC

Skin symptom/complaint other

1.7

28.6

612

3738

PJ2AE

NOMESCO Finland

Lymphnode ultrasound examination

11.9

28.4

N02BE01

ATC

paracetamol; systemic, rectal

1.5

27.9

3377

30395

C43.6

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of upper limb, including shoulder

283.2

27.8

UKC02

NOMESCO Finland

Cystoscopy

1.8

27.5

509

2966

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

27.2

404

2181

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

27.1

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

27.1

UJF32

NOMESCO Finland

Coloscopy

1.6

26.9

843

5716

L04AX01

ATC

azathioprine; systemic

2.5

26.9

213

864

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

75.6

26.8

B03XA02

ATC

darbepoetin alfa; parenteral

5.1

26.7

168

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

11.5

26.3

XKD00

NOMESCO Finland

Uroflowmetry

1.8

26.2

470

2713

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

26.1

L01XE23

ATC

[U] dabrafenib; oral

+∞

26.1

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

26.1

L01AX03

ATC

temozolomide; systemic

+∞

26.1

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

26.1

C43.73

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip nodular

+∞

26.1

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

12.2

25.9

WX302

NOMESCO Finland

Thoracal epidural anesthesy

3.4

25.9

130

393

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

17.5

25.7

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

93.9

25.7

WX110

NOMESCO Finland

Local anesthesy

1.4

25.6

2715

23531

B05DA

ATC

Isotonic solutions

8.0

25.6

TK800

NOMESCO Finland

Hemodialysis

3.9

25.3

105

271

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

50.3

25.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

25.1

307

1534

ZZA00

NOMESCO Finland

Split skin graft

3.8

25.1

109

293

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.6

25.1

188

739

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.6

25.0

185

722

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

25.0

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

25.0

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

25.0

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

25.0

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

25.0

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

25.0

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

8.4

25.0

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

251.5

24.7

ZX070

NOMESCO Finland

Intensity modified radiotherapy

90.6

24.7

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

32.2

24.6

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

32.2

24.6

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

24.4

657

4272

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.1

24.3

135

440

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

24.0

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

+∞

24.0

B07.9

ICD-10 Finland

Verruca simplex

2.7

23.8

163

609

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

125.7

23.6

L02AE02

ATC

leuprorelin; implant, parenteral

4.7

23.5

171

J01MA02

ATC

ciprofloxacin; systemic

1.4

23.4

1338

10299

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

23.4

685

4549

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

6.5

23.3

N02AA05

ATC

oxycodone; systemic

1.9

23.2

340

1824

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

23.0

977

7078

WX002

NOMESCO Finland

Sedation and analgesia

1.6

23.0

657

4339

167

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

22.9

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

22.9

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

22.9

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.1

22.7

272

1349

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

231.1

22.6

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

7.4

22.6

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

5.3

22.6

131

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

120.6

22.6

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.1

22.4

125

409

B05DB

ATC

Hypertonic solutions

8.7

22.3

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

6.0

22.2

102

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

5.7

22.1

114

L91.0

ICD-10 Finland

Hypertrophic scar

4.3

22.1

192

8090/3-C44.2

ICD-O-3

Basal cell carcinoma, NOS, of external ear

+∞

21.9

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

+∞

21.9

1509

Kela drug reimbursment

Dabrafenib (adjuvant treatment)

+∞

21.9

3024

Kela drug reimbursment

Dabrafenib and trametinib (adjuvant treatment)

+∞

21.9

A02BC02

ATC

pantoprazole; systemic

1.4

21.8

2315

19778

PJA10

NOMESCO Finland

Exploration of lymph nodes

12.3

21.8

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

12.3

21.8

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

80.5

21.7

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

22.3

21.7

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

221.0

21.6

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

115.6

21.6

QBA10

NOMESCO Finland

Incision of skin of trunk

5.5

21.5

118

DAB00

NOMESCO Finland

Excision of lesion of auricle

7.4

21.4

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

3.3

21.3

111

346

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

20.8

L02BG06

ATC

exemestane; oral

+∞

20.8

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

20.8

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

19.5

20.8

R31

ICD-10 Finland

Unspecified haematuria

1.9

20.8

297

1579

WZC30

NOMESCO Finland

Teaching

1.8

20.6

349

1969

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.9

20.6

127

446

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

3.1

20.5

115

379

TPH07

NOMESCO Finland

Cathetrisation of artery

2.0

20.4

288

1520

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

20.3

284

1497

TQW40

NOMESCO Finland

Remowal of suture of skin

2.1

20.2

238

1173

QCE99

NOMESCO Finland

Other excision or repair of lesion of skin of upper limb

9.4

20.0

Z94.4

ICD-10 Finland

Liver transplant status

11.3

19.9

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

11.3

19.9

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

19.8

C43.63

ICD-10 Finland

Malignant melanoma of upper extremity including shoulder nodular

+∞

19.8

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

200.8

19.6

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

19.5

752

5311

J05AB11

ATC

valaciclovir; oral

1.7

19.5

451

2803

Z49.2

ICD-10 Finland

Other dialysis

6.6

19.4

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.5

19.4

104

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.7

19.4

232

D22.0

ICD-10 Finland

Melanocytic naevi of lip

10.1

19.3

ZXA10

NOMESCO Finland

Bilateral

1.5

19.0

623

4236

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

5.2

19.0

115

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

18.9

1359

10803

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

18.8

C43.42

ICD-10 Finland

Malignant melanoma of the scalp and neck: 'superficial spreading' type

+∞

18.8

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

18.8

KA1AE

NOMESCO Finland

Kidney ultrasound examination

3.4

18.7

281

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

9.8

18.6

TQB05

NOMESCO Finland

Puncture of skin of trunk

9.3

18.6

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

100.4

18.6

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

190.7

18.5

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

30.1

18.3

B03XA01

ATC

erythropoietin; parenteral

7.2

18.2

ZX112

NOMESCO Finland

Subcutaneous

5.3

18.1

105

362

Kela drug reimbursment

Dabrafenib, trametinib and vemurafenib

+∞

17.7

8720/3-C44.3

ICD-O-3

Malignant melanoma, NOS, of skin of other and unspecified parts of face

+∞

17.7

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

17.7

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

17.7

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

17.7

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

17.7

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

20.1

17.7

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.2

17.6

181

837

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

4.9

17.6

117

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.9

17.5

263

1420

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

180.6

17.5

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

180.6

17.5

HAE99

NOMESCO Finland

Other reconstruction of breast

17.0

17.4

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

17.3

184

866

KCD02

NOMESCO Finland

Transurethral resection of bladder

12.6

17.1

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

5.5

17.0

H02AB04

ATC

methylprednisolone; systemic

1.6

16.8

500

3318

S21

ICPC

Skin texture symptom/complaint

1.6

16.8

419

2656

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

5.8

16.7

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

16.7

L01XE25

ATC

[U] trametinib; oral

+∞

16.7

1CD02

NOMESCO Finland

+∞

16.7

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

16.7

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

16.7

L03AB05

ATC

interferon alfa-2b; parenteral

12.7

16.6

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

170.6

16.5

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

170.6

16.5

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

23.1

16.4

JN6AD

NOMESCO Finland

CT of torso and neck

10.1

16.4

J01CA04

ATC

amoxicillin; systemic

1.4

16.3

3244

29818

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

40.2

16.3

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

16.2

245

1329

R50.9

ICD-10 Finland

Fever, unspecified

1.6

16.2

437

2827

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

16.2

570

3933

N63

ICD-10 Finland

Unspecified lump in breast

2.1

16.0

184

898

TQW40

SPAT

2.5

15.8

122

492

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

7.1

15.8

WW500

NOMESCO Finland

Blood transfusion

3.0

15.8

307

DAB10

NOMESCO Finland

Partial excision of auricle

60.2

15.7

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

33.5

15.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

15.7

814

6072

Z49.1

ICD-10 Finland

Extracorporeal dialysis

3.9

15.7

166

WW200

NOMESCO Finland

Immunization

2.7

15.6

106

397

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

15.6

JN5PN

NOMESCO Finland

Isotope imaging of secondary neoplasms of thyroid origin

+∞

15.6

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

15.6

V03AE01

ATC

polystyrene sulfonate; oral

4.5

15.6

124

Z51.0

ICD-10 Finland

Radiotherapy session

85.4

15.6

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.5

15.5

120

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

160.5

15.5

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

160.5

15.5

J05AB01

ATC

aciclovir; systemic

1.4

15.4

716

5227

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

38.2

15.4

XJH00

NOMESCO Finland

Transanal ultrasonography

2.1

15.2

167

799

D23.6

ICD-10 Finland

Benign neoplasm: Skin of upper limb, including shoulder

5.3

15.1

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

7.1

15.0

A98

ICPC

Health maint/preventive medicine

1.7

14.9

4067

39196

ZXC96

NOMESCO Finland

Robot assisted procedure

5.6

14.9

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

6.5

14.9

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

15.1

14.8

D06BX02

ATC

ingenol mebutate; topical

4.8

14.7

100

KA1MN

NOMESCO Finland

Glomerular filtration rate (GFR) Isotope mesurement

11.3

14.7

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

25.1

14.7

8070/3-C44.4

ICD-O-3

Squamous cell carcinoma, NOS, of skin of scalp and neck

+∞

14.6

C43.40

ICD-10 Finland

Malignant melanoma of the scalp and neck without histology

+∞

14.6

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

14.6

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

+∞

14.6

N18.8

ICD-10 Finland

Other chronic renal failure

2.8

14.6

325

TK820

NOMESCO Finland

Peritoneal dialysis

7.0

14.5

BAA60

NOMESCO Finland

Total thyroidectomy

3.0

14.5

269

ZZA50

NOMESCO Finland

Full thickness skin graft

14.2

14.5

D17.1

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

2.5

14.5

117

485

128

Kela drug reimbursment

Cancers of female genital organs

150.4

14.5

C90.0

ICD-10 Finland

Multiple myeloma

150.4

14.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

150.4

14.5

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

36.1

14.4

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

3.7

14.4

174

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

15.4

14.4

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

4.3

14.4

121

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

7.5

14.4

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

14.3

219

1195

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

19.2

14.2

XW000

NOMESCO Finland

Bone marrow biopsy

2.6

14.2

100

383

H02AB09

ATC

hydrocortisone; systemic

2.9

14.1

307

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.0

14.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.7

13.9

311

1912

B01AB10

ATC

tinzaparin; parenteral

2.1

13.9

158

770

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

13.8

307

1886

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.8

771

5817

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

23.8

13.8

N02AX02

ATC

tramadol; systemic, rectal

1.3

13.7

1360

11229

9734

FHL

Excision and local plastic or associated free skin grafting

6.0

13.7

J01FA10

ATC

azithromycin; systemic

1.3

13.6

2229

19666

C43.82

ICD-10 Finland

Overall malignant melanoma of the skin: 'superficial spreading' type

+∞

13.5

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

13.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

13.5

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

13.5

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

13.5

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

+∞

13.5

C43.00

ICD-10 Finland

Malignant melanoma of the lip without histology

+∞

13.5

C43.49

ICD-10 Finland

Malignant melanoma of the scalp and neck other or unspecified histology

+∞

13.5

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

13.5

258

1512

A79

ICPC

Malignancy NOS

34.1

13.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

140.4

13.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

140.4

13.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

9.4

13.4

J01AA02

ATC

doxycycline; systemic

1.3

13.3

2907

26566

A02BC01

ATC

omeprazole; systemic

1.4

13.2

910

7106

HAE05

NOMESCO Finland

Reconstruction of breast using soft tissue and prosthesis

40.2

13.1

C44

ICD-10 Finland

Other malignant neoplasms of skin

40.2

13.1

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

3.8

13.1

147

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

13.1

1910

16566

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

13.0

119

526

KAC10

NOMESCO Finland

Total nephrectomy with capsule

28.4

12.9

7151

FHL

Kidney transplantation

19.1

12.9

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.4

12.9

186

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

2.4

12.9

112

483

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.9

12.8

270

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

4.5

12.8

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

10.5

12.7

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

9.0

12.7

S26

ICPC

Fear of cancer of skin

4.7

12.7

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

70.0

12.6

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

12.6

205

1145

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

12.5

1036

8311

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

12.5

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

12.5

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

12.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.3

12.5

1259

10388

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

12.5

121

551

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

9.3

12.4

HAB00

NOMESCO Finland

Excision of lesion of mammary gland

2.8

12.4

287

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.8

12.4

207

1166

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

12.4

332

2146

N18.0

ICD-10 Finland

End-stage renal disease

3.9

12.3

126

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

4.1

12.2

112

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

2.7

12.2

301

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

12.2

418

2861

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.5

12.1

363

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.2

12.0

196

4056

NOMESCO Finland

26.7

12.0

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

18.1

12.0

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

12.0

251

1515

J02AC01

ATC

fluconazole; systemic

1.3

12.0

1441

12157

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

3.8

12.0

129

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.0

11.9

220

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.6

11.9

342

2247

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.4

11.9

171

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

46.8

11.9

196

Kela drug reimbursment

Paricalcitol and cinacalcet

7.0

11.8

Z42.1

ICD-10 Finland

Follow-up care involving plastic surgery of breast

9.6

11.7

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

3.6

11.7

142

E04.2

ICD-10 Finland

Nontoxic multinodular goitre

2.2

11.6

117

541

V03AE02

ATC

sevelamer; oral

6.0

11.6

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

11.6

151

776

HAE00

NOMESCO Finland

Reconstruction of breast using prosthesis

18.9

11.6

C03CA01

ATC

furosemide; systemic

1.4

11.5

728

5594

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

11.5

572

4217

A02BC05

ATC

esomeprazole; systemic

1.3

11.5

1347

11315

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

11.5

WB303

NOMESCO Finland

Simple adjuvant therapy of malignancy with biomodifiers

+∞

11.5

XX1XN

NOMESCO Finland

Other isotope examination

+∞

11.5

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

11.5

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

11.5

4CJ01

NOMESCO Finland

+∞

11.5

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

11.5

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

11.5

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

11.5

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

11.5

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

5.6

11.4

QXE99

NOMESCO Finland

Other excision or repair of unspecified region of skin

13.6

11.4

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

120.3

11.4

C44.59

ICD-10 Finland

Malignant tumor of the skin on the trunk other or unspecified histology

120.3

11.4

WF090

NOMESCO Finland

Profylactic radiotherapy

120.3

11.4

3AC01

NOMESCO Finland

3.8

11.4

125

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

11.4

1862

16281

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

4.0

11.3

111

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

11.3

194

1102

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

35.1

11.3

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

11.2

561

4138

KAS20

NOMESCO Finland

Allogenic transplantation of kidney from living donor

17.1

11.2

D07AC01

ATC

betamethasone; topical

1.3

11.1

1164

9620

JJC00

NOMESCO Finland

Allogenic transplantation of liver

8.6

11.0

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

10.9

952

7676

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

43.4

10.9

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

10.9

255

1587

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.5

10.9

369

2518

K06.18

ICD-10 Finland

Another gingival hyperplasia

8.2

10.8

KC1GB

NOMESCO Finland

Cystography with X-ray

10.6

10.7

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

28.1

10.7

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

21.5

10.7

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.7

10.7

265

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

60.1

10.6

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

60.1

10.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

4.2

10.6

JFB30

NOMESCO Finland

Right hemicolectomy

6.3

10.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.6

311

2054

ZX108

NOMESCO Finland

Inhalation

5.7

10.5

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

9.2

10.5

ZZR10

NOMESCO Finland

Flap of skin and muscle

14.2

10.5

R4190

NOMESCO Finland

Nutritional therapy

2.3

10.4

416

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

10.4

L01CA04

ATC

vinorelbine; systemic

+∞

10.4

8070/3-C44.2

ICD-O-3

Squamous cell carcinoma, NOS, of external ear

+∞

10.4

394

Kela drug reimbursment

Palbociclib

+∞

10.4

1501

Kela drug reimbursment

Palbociclib

+∞

10.4

8743/3-C44.7

ICD-O-3

Low cumulative sun damage melanoma of skin of lower limb and hip

+∞

10.4

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

+∞

10.4

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

10.4

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

10.4

WB323

NOMESCO Finland

Demanding adjuvant therapy of malignancy with biomodifiers

+∞

10.4

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

10.4

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

10.4

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

10.4

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

10.4

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

10.4

Z85.8

ICD-10 Finland

Personal history of malignant neoplasms of other organs and systems

+∞

10.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

+∞

10.4

C43.33

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face nodular

+∞

10.4

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

10.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

10.4

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.9

10.4

152

819

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

6.8

10.3

JJ5AT

NOMESCO Finland

16.1

10.3

R01AD09

ATC

mometasone; nasal

1.2

10.3

1638

14220

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

13.1

10.1

M05BX04

ATC

denosumab; parenteral

2.3

10.1

421

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.4

10.1

420

2990

D17.2

ICD-10 Finland

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

2.6

10.1

270

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

10.1

471

3427

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.2

10.1

455

D07AD01

ATC

clobetasol; topical

1.4

10.1

495

3639

D22.2

ICD-10 Finland

Melanocytic naevi of ear and external auricular canal

11.3

10.0

D48.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Breast

3.1

10.0

167

G04BE03

ATC

sildenafil; oral

6.1

10.0

C08CA01

ATC

amlodipine; oral

1.3

9.9

1025

8435

KA3AT

NOMESCO Finland

Biopsy of kidney with ultrasound guidance

3.5

9.9

131

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

7.6

9.9

Z94.9

ICD-10 Finland

Transplanted organ and tissue status, unspecified

12.2

9.8

HAD30

NOMESCO Finland

Reduction mammoplasty with transposition of areola

2.2

9.8

447

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

8.1

9.8

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

5.9

9.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

9.8

463

3381

XF612

NOMESCO Finland

Measurement of central venous pressure

10.6

9.8

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

9.8

1008

8296

S15

ICPC

Foreign body in skin

1.7

9.8

182

1065

K07.60

ICD-10 Finland

Snapping jaw

1.7

9.7

189

1120

H02AB06

ATC

prednisolone; systemic

1.2

9.7

1565

13579

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

9.7

304

2040

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

13.4

9.7

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.7

9.6

236

K65.0

ICD-10 Finland

Acute peritonitis

4.1

9.6

ZZF00

NOMESCO Finland

Graft of adipose tissue

6.8

9.6

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.5

9.6

363

2537

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

9.6

365

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

1.9

9.5

145

794

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

5.0

9.5

Z94.1

ICD-10 Finland

Heart transplant status

10.0

9.5

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

10.0

9.5

L02AE03

ATC

goserelin; implant

4.7

9.5

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

9.4

1425

12265

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

100.2

9.4

C43.9

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of skin, unspecified

100.2

9.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

9.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

9.4

3016

Kela drug reimbursment

Binimetinib and encorafenib

+∞

9.4

L01EC02

ATC

dabrafenib; oral

+∞

9.4

C44.40

ICD-10 Finland

Malignant tumor of the skin of the scalp and neck without histology

+∞

9.4

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

9.4

8742/3-C44.9

ICD-O-3

Lentigo maligna melanoma of skin, NOS

+∞

9.4

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

9.4

C43.90

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin without histology

+∞

9.4

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

9.4

8090/3-C44.0

ICD-O-3

Basal cell carcinoma, NOS, of skin of lip, NOS

+∞

9.4

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

9.4

C81.9

ICD-10 Finland

Hodgkin lymphoma, unspecified

+∞

9.4

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

9.4

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

9.4

8094/3-C44.9

ICD-O-3

Basosquamous carcinoma of skin, NOS

+∞

9.4

D18.0

ICD-10 Finland

Haemangioma, any site

2.4

9.3

307

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.9

9.3

127

671

TPX15

NOMESCO Finland

Removal of vascular injection port

10.7

9.3

5AB14

NOMESCO Finland

9.5

9.2

G04CA02

ATC

tamsulosin; oral

1.3

9.2

597

4594

D07AB08

ATC

desonide; topical

1.5

9.2

339

2355

D01AE16

ATC

amorolfine; topical

1.5

9.2

350

2447

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

9.2

134

723

E89.01

ICD-10 Finland

Postsurgical hypothyroidism

3.0

9.1

163

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.6

9.0

256

1675

N64.9

ICD-10 Finland

Disorder of breast, unspecified

3.6

9.0

105

HA1CM

NOMESCO Finland

Mammary gland extensive MRI examination with 3 Tesla magnet

18.6

8.9

D75

ICPC

Malignant neoplasm colon/rectum

24.0

8.9

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

5.7

8.9

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.7

8.9

184

1112

ZX114

NOMESCO Finland

Intramuscular

3.0

8.9

160

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

8.9

396

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.8

8.8

143

801

D02AX

ATC

Other emollients and protectives

2.0

8.8

111

569

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.8

195

1202

BBA40

NOMESCO Finland

Subtotal parathyroidectomy

6.3

8.8

D10BA01

ATC

isotretinoin; oral

1.6

8.7

228

1464

N03.9

ICD-10 Finland

Chronic nephritic syndrome, unspecified

5.9

8.7

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

5.6

8.7

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.4

8.7

119

RS220

NOMESCO Finland

3.0

8.6

158

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

5.2

8.6

QXB05

NOMESCO Finland

Skin wound assessment, unspecified location

8.2

8.6

J01FF01

ATC

clindamycin; systemic

1.3

8.5

883

7253

WXQ99

NOMESCO Finland

Other light therapy

16.3

8.5

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

8.5

1188

10107

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.5

8.5

247

5602

FHL

Internal fistula (eg Cimino)

27.5

8.5

WX704

NOMESCO Finland

Intubation

1.6

8.5

206

1299

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.4

358

2560

BE00A

NOMESCO Finland

90.2

8.4

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

90.2

8.4

J01MA12

ATC

levofloxacin; systemic

1.4

8.4

487

3684

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.9

8.4

164

B02AA02

ATC

tranexamic acid; systemic

1.4

8.4

461

3454

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

2.5

8.3

243

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

8.3

380

8091/3-C44.9

ICD-O-3

Superficial basal cell carcinoma of skin, NOS

+∞

8.3

8140/3-C18.6

ICD-O-3

Adenocarcinoma, NOS, of descending colon

+∞

8.3

8743/3-C44.6

ICD-O-3

Low cumulative sun damage melanoma of skin of upper limb and shoulder

+∞

8.3

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

8.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

8.3

C43.29

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal other or unspecified histology

+∞

8.3

197

Kela drug reimbursment

Sunitinib

+∞

8.3

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

8.3

3054

Kela drug reimbursment

+∞

8.3

1523

Kela drug reimbursment

+∞

8.3

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

8.3

PJW99

NOMESCO Finland

Other operation on lymphatic system

+∞

8.3

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

8.3

C43.22

ICD-10 Finland

Malignant melanoma of outer ear and outer ear canal: 'superficial spreading' type

+∞

8.3

1513

Kela drug reimbursment

Binimetinib and encorafenib

+∞

8.3

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

8.3

WX1DG

NOMESCO Finland

Very extensive total body MRI with high intensity magnet

+∞

8.3

8720/3-C44.4

ICD-O-3

Malignant melanoma, NOS, of skin of scalp and neck

+∞

8.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

8.3

L02BB04

ATC

enzalutamide; oral

+∞

8.3

D02AE01

ATC

carbamide; topical

1.6

8.3

211

1348

R01AD12

ATC

fluticasone furoate; nasal

1.2

8.3

1053

8861

NK6MA

NOMESCO Finland

Measurement of bone age from hand and elbow using X-ray

5.5

8.3

WF099

NOMESCO Finland

Other radiotherapy

14.5

8.2

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

2.8

8.2

175

M04AA01

ATC

allopurinol; systemic

1.5

8.2

309

2162

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

8.2

211

1353

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

7.5

8.1

QAE00

NOMESCO Finland

Excision of loose skin or fold of skin from head and neck

7.5

8.1

205

Kela drug reimbursment

Chronic hypertension

1.3

8.1

753

6096

Z01.7

ICD-10 Finland

Laboratory examination

1.4

8.1

352

2530

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

33.4

8.1

HA1HA

NOMESCO Finland

Tomosynthesis mammography

11.7

8.1

L01BB01

ATC

6.8

8.0

P01AB01

ATC

metronidazole; oral, rectal

1.2

8.0

1332

11537

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

5.2

8.0

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

8.0

1007

8462

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

4.9

7.9

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

7.9

498

3816

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

7.8

321

2283

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

3.1

7.7

125

6119

FHL

Other measure in this category

45.0

7.7

6112

FHL

Installation of a peritoneal dialysis or lavage catheter in an operating room

45.0

7.7

187

Kela drug reimbursment

MPA

45.0

7.7

TBW99

NOMESCO Finland

Other minor procedure in endocrine surgery

5.0

7.7

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.5

7.7

239

1602

F16

ICPC

Eyelid symptom/complaint

1.7

7.6

148

883

A06AH03

ATC

naloxegol; oral

6.7

7.6

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

7.6

1288

11169

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

25.0

7.6

C09CA06

ATC

candesartan; oral

1.3

7.6

646

5170

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.9

7.6

PH1AE

NOMESCO Finland

Ultrasound examination of upper extremity veins

3.1

7.5

122

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

5.4

7.5

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.6

7.5

1675

XCK10

NOMESCO Finland

Photography of fundus of eye

1.5

7.5

286

2005

A06AC01

ATC

ispaghula (psylla seeds); oral

1.3

7.4

700

5674

N08.2*D89.80

ICD-10 Finland

Immunoglobulin A (IgA) nephropathy

3.8

7.4

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

80.2

7.4

153

Kela drug reimbursment

Lenalidomid

80.2

7.4

L04AX04

ATC

lenalidomide; oral

80.2

7.4

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

1.8

7.4

115

637

SBB00

NOMESCO Finland

Fotograf of mouth and teeth

1.8

7.4

117

653

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.6

7.4

201

1310

321

Kela drug reimbursment

Paricalcitol and cinacalcet

5.3

7.4

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

7.3

103

ICD-10 Finland

2.1

7.3

357

T71

ICPC

Malignant neoplasm thyroid

+∞

7.3

WB223

NOMESCO Finland

Demanding adjuvant hormone therapy of malignancy

+∞

7.3

8721/3-C44.9

ICD-O-3

Nodular melanoma of skin, NOS

+∞

7.3

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

7.3

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

7.3

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

+∞

7.3

8720/3-C44.2

ICD-O-3

Malignant melanoma, NOS, of external ear

+∞

7.3

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

+∞

7.3

8070/3-C44.5

ICD-O-3

Squamous cell carcinoma, NOS, of skin of trunk

+∞

7.3

L02BX02

ATC

degarelix; parenteral

+∞

7.3

159

Kela drug reimbursment

Pazopanib

+∞

7.3

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

C73.99

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland), other or unspecified histology

+∞

7.3

192

Kela drug reimbursment

Fulvestrant

+∞

7.3

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

7.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

7.3

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

+∞

7.3

C43.74

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip acral

+∞

7.3

D03.30

ICD-10 Finland

Melanoma in situ on the lip

+∞

7.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

7.3

9835/3-C42.1

ICD-O-3

Precursor cell lymphoblastic leukemia, NOS, of bone marrow

+∞

7.3

B25.9

ICD-10 Finland

Cytomegaloviral disease, unspecified

9.4

7.3

ZXB10

NOMESCO Finland

Medial

4.1

7.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

7.3

391

2918

L85.3

ICD-10 Finland

Xerosis cutis

3.2

7.3

109

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.5

7.2

243

1659

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

4.5

7.2

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

2.4

7.2

237

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

5.1

7.2

L02AE04

ATC

triptorelin; parenteral

15.7

7.2

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

7.2

104

562

S97

ICPC

Chronic ulcer skin

1.7

7.2

144

862

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

7.3

7.2

C08CA02

ATC

felodipine; oral

1.5

7.2

239

1630

QB5S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in back

30.0

7.1

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

30.0

7.1

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

20.0

7.1

XF404

NOMESCO Finland

Ambulatory ECG

1.4

7.1

278

1957

C08CA13

ATC

lercanidipine; oral

1.4

7.1

337

2463

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.7

7.1

129

752

JHA10

NOMESCO Finland

Biopsy of anal canal

12.0

7.1

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

7.1

265

1851

XF602

NOMESCO Finland

Bloodpressure monitoring

3.1

7.1

117

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.8

7.0

C02AC05

ATC

moxonidine; oral

1.8

7.0

123

708

ZX197

NOMESCO Finland

10.0

7.0

Z99.2

ICD-10 Finland

Dependence on renal dialysis

10.0

7.0

N03AX16

ATC

pregabalin; oral

1.3

7.0

680

5530

R51.80

ICD-10 Finland

Headache

1.3

7.0

488

3793

B35.1

ICD-10 Finland

Tinea unguium

1.6

7.0

169

1070

H05BX01

ATC

cinacalcet; oral

4.7

7.0

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

7.0

378

TJA33

NOMESCO Finland

Percutaneous introduction of peritoneal dialysis catheter

6.3

6.9

K50.8

ICD-10 Finland

Other Crohn disease

2.4

6.9

230

L90.5

ICD-10 Finland

Scar conditions and fibrosis of skin

3.2

6.9

108

104

Kela drug reimbursment

Thyroid insufficiency

1.6

6.9

188

1224

TQX05

NOMESCO Finland

Skin puncture, unspecified location

7.5

6.9

5828A

ICD-9 Finland

Chronic glomerulonephritis, With other specified pathological lesion in kidney[GLOMERULONEPHRITIS CHRONICA ALIA DEF,EI NEFR SDR]

13.8

6.9

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.2

6.9

304

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

2.4

6.8

214

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

3.7

6.8

X59

ICD-10 Finland

Exposure to unspecified factor

1.3

6.8

582

4655

D48.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other specified sites

4.4

6.8

C08CA05

ATC

nifedipine; systemic

1.6

6.8

173

1107

S52

ICPC

Skin, Exc/remov/biopsy/destruc/debrid/caut

6.7

6.8

K50.1

ICD-10 Finland

Crohn disease of large intestine

2.6

6.8

179

L04AA05

ATC

[U] tacrolimus; systemic

10.9

6.8

N03.8

ICD-10 Finland

Chronic nephritic syndrome, other

9.3

6.8

HAD40

NOMESCO Finland

Mastopexy

6.1

6.8

PG5RT

NOMESCO Finland

PTA of arterio-venous shunt for dialysis

6.1

6.8

A54

ICPC

General and Unspecified, Repair/fix-suture/cast/prosth device

2.5

6.7

209

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.0

6.7

381

JN3AD

NOMESCO Finland

Abdominal CT examination

1.6

6.7

180

1167

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

6.7

276

WX320

NOMESCO Finland

Spinalanesthesy

1.3

6.7

681

5570

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

22.5

6.7

Z01.2

ICD-10 Finland

Dental examination

1.2

6.7

1445

12794

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

1.4

6.6

262

1851

I78.19

ICD-10 Finland

Other nevus (non-neoplastic)

5.2

6.6

602

Kela drug reimbursment

Children's severe malnutrition

7.8

6.6

B01AB04

ATC

dalteparin; parenteral

1.8

6.6

114

656

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.9

6.6

501

BA1AE

NOMESCO Finland

Thyroiid ultrasound examination

2.5

6.6

188

WX702

NOMESCO Finland

Supraglottic ventilation device

1.6

6.6

156

982

NEA10

NOMESCO Finland

Exploration of soft tissue of pelvis, percutaneous

8.7

6.5

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

6.5

214

1457

QAE15

NOMESCO Finland

Excision of other superficial lesion of skin from head and neck

10.0

6.5

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

10.0

6.5

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

6.5

468

3659

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

4.1

6.5

L01AA01

ATC

cyclophosphamide; systemic

6.2

6.5

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

5.3

6.4

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

69.9

6.4

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

69.9

6.4

329

Kela drug reimbursment

Lenalidomide

69.9

6.4

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

69.9

6.4

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

1.8

6.4

105

595

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

7.4

6.4

Z40.0

ICD-10 Finland

Prophylactic surgery for risk-factors related to malignant neoplasms

14.3

6.4

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

6.4

1010

8668

320

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

4.0

6.4

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.4

293

2132

V03AE03

ATC

lanthanum carbonate; oral

4.9

6.3

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

2.2

6.3

276

HA3AT

NOMESCO Finland

Pucture of mammary gland cyst with ultrasound examination

6.5

6.3

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

8.1

6.3

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

8.1

6.3

JFF23

NOMESCO Finland

Transversostomy

5.9

6.3

T86.1

ICD-10 Finland

Kidney transplant failure and rejection

11.0

6.3

1CX01

NOMESCO Finland

11.0

6.3

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

11.0

6.3

KAC00

NOMESCO Finland

Nephrectomy

11.0

6.3

ZX050

NOMESCO Finland

Stereotactic radiotherapy

9.2

6.3

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

3.2

6.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.2

6.3

290

J01EA01

ATC

trimethoprim; systemic

1.2

6.3

740

6156

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

18.0

6.3

C44.82

ICD-10 Finland

Overall spinocellular carcinoma of the skin

+∞

6.2

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.2

HAC25

NOMESCO Finland

Radical mastectomy

+∞

6.2

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

6.2

C44.29

ICD-10 Finland

Malignant tumor of the skin of the outer ear and in the outer ear canal other or unspecified histology

+∞

6.2

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

6.2

C43.20

ICD-10 Finland

Malignant melanoma of the outer ear and in the external ear canal without histology

+∞

6.2

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

6.2

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

6.2

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

6.2

YN1BD

NOMESCO Finland

Extensive CT examination of extremities for dose design of radiotherapy

+∞

6.2

L02BA03

ATC

fulvestrant; parenteral

+∞

6.2

8500/3-C50.8

ICD-O-3

Infiltrating duct carcinoma, NOS, of overlapping lesion of breast

+∞

6.2

L01EE01

ATC

trametinib; oral

+∞

6.2

C73

ICD-10 Finland

Malignant neoplasm of thyroid gland

+∞

6.2

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

6.2

C49.20

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology

+∞

6.2

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

6.2

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.2

C91.9

ICD-10 Finland

Lymphoid leukaemia, unspecified

+∞

6.2

G04BE30

ATC

drugs used in erectile dysfunction - combinations

+∞

6.2

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

6.2

1733A

ICD-9 Finland

Other malignant neoplasm of skin, Skin of other and unspecified parts of face[KASVOJEN IHON SYÖPÄ,CA BASOCELLULARE]

+∞

6.2

8140/3-C18.4

ICD-O-3

Adenocarcinoma, NOS, of transverse colon

+∞

6.2

L01EF01

ATC

palbociclib; oral

+∞

6.2

C44.92

ICD-10 Finland

Unspecified localization of spinocellular carcinoma of the skin

+∞

6.2

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.2

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

6.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

6.2

8070/3-C44.6

ICD-O-3

Squamous cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

6.2

C43.89

ICD-10 Finland

Overall malignant melanoma of the skin other or unspecified histology

+∞

6.2

C49.29

ICD-10 Finland

Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor

+∞

6.2

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

6.2

3AA13

NOMESCO Finland

+∞

6.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

6.2

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

+∞

6.2

1XC07

NOMESCO Finland

+∞

6.2

8721/3-C44.5

ICD-O-3

Nodular melanoma of skin of trunk

+∞

6.2

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.2

6.2

270

V03AG01

ATC

sodium cellulose phosphate; systemic

26.7

6.2

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.7

6.2

121

725

Z71.8

ICD-10 Finland

Other specified counselling

1.2

6.2

785

6582

QDA99

NOMESCO Finland

Other local destruction of skin of lower limb

6.3

6.1

D24

ICD-10 Finland

Benign neoplasm of breast

2.2

6.1

253

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

6.1

134

829

K05.30

ICD-10 Finland

Periodontitis complex

1.4

6.1

350

2640

1XC02

NOMESCO Finland

4.2

6.1

UJH02

NOMESCO Finland

Anoscopy

1.7

6.1

122

737

BAA40

NOMESCO Finland

Unilateral lobectomy of thyroid gland

2.2

6.1

276

QXA05

NOMESCO Finland

Skin division, unspecified location

4.6

6.1

WW200

SPAT

0.7

6.0

192

2702

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.4

6.0

253

1810

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.0

1109

9654

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

10.0

6.0

XQ800

NOMESCO Finland

Prick test

1.4

6.0

243

1726

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

2.5

6.0

172

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3002256) Pathology report gross observation

1442

3347

5.69

307.65

1.8

1.1

—

(40768804) Tissue Pathology biopsy report

2949

13463

4.00

307.65

3.2

1.7

—

(4035726)

702

1165

6.87

307.65

1.6

1.2

—

(3010375) cycloSPORINE [Mass/volume] in Blood

137

136

10.34

122.13

27.8

20.7

97.7

113.3

ug/l

1.46

119

105

(40768443) Skin Pathology biopsy report

463

1470

3.37

117.42

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

744

3160

2.60

111.04

5.9

2.9

238.0

229.2

u/l

0.58

714

2945

(3013650) Neutrophils [#/volume] in Blood by Automated count

2897

20970

1.94

106.04

11.5

6.7

3.9

4.2

e9/l

7.34

2591

18179

(3024561) Albumin [Mass/volume] in Serum or Plasma

2154

14332

1.90

99.99

6.9

3.9

36.3

g/l

0.16

2056

13182

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

469

1650

3.04

99.66

3.8

1.6

5.0

11.9

ug/l

0.43

361

1191

(3026250) Tacrolimus [Mass/volume] in Blood

123

142

8.86

97.92

34.9

35.3

6.8

7.6

ug/l

2.86

104

131

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2462

17407

1.84

91.48

8.0

3.8

11.0

11.3

umol/l

0.77

2345

16283

(3001604) Monocytes [#/volume] in Blood

2597

19046

1.78

81.78

8.2

5.6

0.6

e9/l

0.13

2304

16565

(3019198) Lymphocytes [#/volume] in Blood

2659

19654

1.77

81.31

8.1

5.6

1.9

e9/l

0.11

2398

17424

(3006315) Basophils [#/volume] in Blood

2605

19143

1.77

81.26

8.2

5.6

0.0

e9/l

0.90

2311

16643

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

224

565

4.11

79.23

8.3

5.3

830.9

580.6

iu/ml

0.27

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3496

28149

1.85

78.66

10.2

5.4

75.3

74.4

u/l

0.51

3340

26240

(3013115) Eosinophils [#/volume] in Blood

2661

19815

1.75

77.92

8.4

5.7

0.2

e9/l

2.99

2395

17518

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2334

16965

1.72

72.58

10.0

5.5

1.2

mmol/l

0.14

2031

14308

(3033658) Prothrombin time (PT) actual/Normal

1374

8691

1.81

68.87

5.0

3.4

91.8

90.9

0.63

1346

8449

(42870588) Differential panel, method unspecified - Blood

1802

12371

1.72

67.61

8.0

5.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2115

15201

1.69

66.69

8.5

5.1

1.2

mmol/l

0.05

1967

13607

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

177

426

4.27

66.59

4.6

2.6

625.6

569.5

u/ml

0.04

(40768793) Breast Pathology biopsy report

144

296

4.98

65.83

1.3

1.2

—

(3018418) pH of Serum or Plasma

1489

9786

1.75

64.69

6.5

3.2

7.4

2.07

233

1744

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

28.91

64.18

1.0

1.5

1.4

ug/l

—

(3019069) Monocytes/100 leukocytes in Blood

2376

17823

1.65

61.92

8.7

6.0

8.5

8.4

0.35

2280

16639

(3002582) Erythrocytes [#/volume] in Urine

1566

10539

1.72

61.91

4.4

2.9

40.2

85.6

e6/l

1.82

1240

7933

(3015377) Calcium [Moles/volume] in Serum or Plasma

1610

10932

1.71

61.51

4.7

2.0

2.3

mmol/l

0.06

1441

9362

(3012095) Magnesium [Moles/volume] in Serum or Plasma

875

4955

1.93

61.32

5.4

2.7

0.8

mmol/l

1.51

823

4585

(3006504) Eosinophils/100 leukocytes in Blood

2361

17717

1.64

61.16

8.5

5.7

2.9

0.84

2246

16427

(3002030) Lymphocytes/100 leukocytes in Blood

2434

18410

1.64

61.05

8.5

5.7

28.5

28.8

0.61

2325

17096

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

14.25

60.45

8.2

1.2

—

(3022096) Basophils/100 leukocytes in Blood

2291

17152

1.63

59.22

8.7

5.8

0.7

0.01

2188

15918

(3018010) Neutrophils/100 leukocytes in Blood

2404

18224

1.63

58.99

8.2

5.6

57.0

56.8

0.46

2296

16992

(3030467) Casts [#/volume] in Urine by Automated count

1448

9642

1.71

58.93

4.2

2.8

0.3

0.4

e6/l

0.73

1117

7113

(3018095) Leukocytes [#/volume] in Urine

1809

12785

1.66

58.67

4.9

3.3

47.5

91.5

e6/l

1.44

1331

8662

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

974

5784

1.85

58.67

3.3

2.5

1.3

1.1

e6/l

0.18

603

3230

(3003458) Phosphate [Moles/volume] in Serum or Plasma

770

4236

1.97

58.52

11.6

5.5

1.1

1.0

mmol/l

1.00

729

3930

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

103

7.78

56.91

3.1

2.6

—

(40758558) Short blood count panel - Blood

1323

8739

1.70

54.72

9.6

5.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

895

5300

1.84

53.92

3.5

2.6

2.0

2.9

e6/l

3.23

527

2762

(3020779) Urea [Moles/volume] in Serum or Plasma

564

2857

2.10

53.59

14.4

7.3

10.3

9.6

mmol/l

1.60

545

2724

(3019420) Tryptase [Mass/volume] in Serum or Plasma

103

193

5.43

52.29

1.2

1.4

5.7

8.4

ug/l

1.37

162

(3021589) Normoblasts [#/volume] in Blood

2235

16996

1.58

51.58

11.5

8.0

0.0

e9/l

0.32

1825

13907

(36304419) Bacteria [Presence] in Urine

1396

9479

1.66

51.42

4.0

2.8

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

507

2510

2.14

51.04

6.7

3.8

106.2

88.4

ng/l

3.23

465

2175

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

247

877

2.91

51.01

7.2

3.2

1.7

1.5

mg/l

3.62

233

802

(40768795) Lymph node Pathology biopsy report

8.10

50.74

1.3

1.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2217

16871

1.57

50.71

4.2

3.7

—

(3002385) Erythrocyte distribution width [Ratio]

3885

33793

1.73

50.47

21.4

13.3

13.6

13.5

1.66

3826

33023

(3000850) Epithelial cells [#/volume] in Urine

1130

7355

1.70

48.43

3.5

2.4

3.6

6.1

e6/l

17.45

1008

6362

(3044640) Blood type and Crossmatch panel - Blood

1525

10734

1.61

47.95

2.6

2.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

691

3924

1.89

46.99

7.3

6.4

104.6

104.5

mmol/l

0.06

685

3832

(3026782) Osmolality of Urine

1038

6710

1.69

45.23

3.9

2.5

512.4

549.1

mosm/kgh2o

0.41

899

5622

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

918

5738

1.74

45.23

3.6

2.0

2.4

mmol/l

0.65

817

4884

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1691

12475

1.54

42.08

4.2

2.7

29.7

33.3

u/l

1.48

1617

11820

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

183

618

3.04

41.29

3.3

2.2

200.9

108.2

u/ml

0.27

153

496

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

4382

40127

1.89

39.83

17.2

11.1

22.4

21.5

mg/l

0.95

3491

30794

(3031040) Bacteria [#/volume] in Urine by Automated count

3012

25240

1.50

39.73

4.9

4.0

139.3

1543.1

e6/l

3.15

321

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

8.70

39.61

5.3

5.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

12.76

39.17

4.5

1.1

24.2

17.9

u/ml

0.81

(3000991) Gas panel - Venous blood

487

2633

1.94

38.01

9.9

8.1

—

(3013707) Erythrocyte sedimentation rate by Westergren method

3395

29287

1.52

37.99

4.7

3.9

10.9

10.6

mm/h

0.73

3173

27279

(3032080) INR in Blood by Coagulation assay

1789

13600

1.50

37.51

9.4

8.7

1.2

inr

1.10

486

4095

(3037467) Urinalysis macro (dipstick) panel - Urine

3170

26995

1.50

37.45

5.3

3.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

155

506

3.13

37.08

1.3

1.2

—

(3044889) 12 lead EKG panel

3114

26526

1.48

35.89

4.1

3.5

—

(3023368) Bacteria identified in Blood by Culture

1193

8387

1.56

35.72

4.7

3.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

2626

21657

1.46

35.68

5.9

4.2

6.6

mmol/l

0.46

2464

19900

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

2014

15793

1.47

35.57

2.6

2.2

78.6

76.0

nmol/l

4.21

1860

14317

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

8.56

35.22

1.2

1.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

784

5029

1.67

34.16

3.8

2.5

2.3

2.4

g/l

4.75

742

4630

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

727

4595

1.68

33.46

3.9

2.6

23.3

23.8

0.40

640

3914

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

630

3833

1.74

33.34

3.9

2.3

6.1

7.0

umol/l

1.12

555

3267

(3017143) Hepatitis C virus Ab [Presence] in Serum

760

4872

1.66

33.11

2.1

1.6

—

(40761511) CBC panel - Blood by Automated count

4526

42382

1.92

31.19

15.2

10.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

538

3193

1.77

30.93

2.8

2.2

35.6

51.8

u/l

0.53

471

2695

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1140

8152

1.52

30.87

2.5

2.0

—

(3022948) Iron [Moles/volume] in Serum or Plasma

828

5520

1.60

30.60

3.7

2.5

13.3

13.9

umol/l

1.49

790

5082

(3019550) Sodium [Moles/volume] in Serum or Plasma

4371

40554

1.74

30.40

19.3

12.6

139.7

mmol/l

0.37

4301

39438

(3023103) Potassium [Moles/volume] in Serum or Plasma

4382

40692

1.75

30.28

19.6

12.7

3.9

4.0

mmol/l

2.59

4309

39486

(3035637) Corticotropin [Mass/volume] in Plasma

117

366

3.25

30.09

1.7

1.4

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

520

3080

1.77

30.07

5.8

3.7

5.9

5.8

kpa

0.01

502

2979

(40768800) Prostate Pathology biopsy report

185

4.27

30.00

1.2

1.1

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

518

3076

1.77

29.67

1.6

1.4

—

(3002032) Base excess in Venous blood by calculation

517

3072

1.76

29.55

5.9

3.7

1.3

1.9

mmol/l

2.95

425

2488

(3007853) Bacteria identified in Skin by Aerobe culture

673

4299

1.66

29.47

2.1

1.7

—

(3042936) Bacteria identified in Isolate by Culture

731

4769

1.63

29.43

2.3

2.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4561

42921

1.94

29.42

13.1

8.4

25.6

26.1

u/l

0.80

4451

41334

(3035941) MCH [Entitic mass]

4754

45467

2.69

29.34

25.3

16.4

30.2

30.3

0.93

4718

44840

(3024731) MCV [Entitic volume]

4754

45467

2.69

29.34

25.4

16.4

90.7

0.01

4718

44839

(3007461) Platelets [#/volume] in Blood

4752

45441

2.67

29.29

25.5

16.5

252.2

253.7

e9/l

0.81

4675

44285

(3010813) Leukocytes [#/volume] in Blood

4755

45487

2.69

29.22

25.5

16.5

6.6

6.7

e9/l

1.96

4664

44198

(3026361) Erythrocytes [#/volume] in Blood

4754

45475

2.68

29.18

25.5

16.5

4.5

e12/l

7.29

4664

44204

(3000963) Hemoglobin [Mass/volume] in Blood

4754

45487

2.67

28.94

25.6

16.6

134.9

136.8

g/l

18.28

4717

44849

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

451

2613

1.80

28.04

2.7

2.2

0.2

g/l

3.67

428

2389

(40760892) CBC W Ordered Manual Differential panel - Blood

1210

8915

1.47

27.86

5.7

4.1

—

(3003396) Base excess in Arterial blood by calculation

565

3500

1.69

27.72

7.1

7.2

0.8

1.1

mmol/l

0.71

449

2654

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

203

886

2.35

27.52

3.1

3.5

0.3

u/ml

0.70

110

511

(3026008) Bacteria identified in Urine by Culture

1372

10412

1.44

26.88

3.2

2.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

771

5198

1.57

26.85

2.9

2.0

29.8

0.02

753

5024

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

311

1621

1.98

26.80

6.5

4.1

23.6

24.2

mmol/l

2.37

284

1441

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

968

6864

1.51

26.77

4.1

3.5

355.7

483.8

ng/l

0.66

719

4962

(3002173) Hemoglobin [Mass/volume] in Arterial blood

479

2881

1.73

26.11

7.8

8.0

119.3

123.9

g/l

4.98

462

2775

(3027801) Oxygen [Partial pressure] in Arterial blood

561

3522

1.67

26.09

7.2

13.0

12.0

kpa

4.10

539

3360

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

561

3522

1.67

26.09

7.2

5.1

5.0

kpa

0.44

540

3365

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

284

1453

2.01

25.79

1.9

1.7

1.4

1.5

g/l

0.36

249

1251

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

186

3.97

25.56

6.7

1.2

212.4

115.8

u/ml

0.24

(3001122) Ferritin [Mass/volume] in Serum or Plasma

2202

18243

1.38

25.51

3.5

2.9

113.6

101.4

ug/l

2.09

2082

17013

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

4069

37437

1.52

25.35

5.4

4.6

1.8

2.0

mu/l

1.10

3838

34655

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

556

3516

1.66

25.10

1.7

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

559

3543

1.65

25.01

1.8

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

301

1589

1.95

24.98

8.7

10.2

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1472

11433

1.41

24.97

3.4

2.3

57.7

58.0

u/l

0.09

1359

10535

(3014111) Lactate [Moles/volume] in Serum or Plasma

463

2806

1.72

24.51

7.5

6.6

1.3

1.4

mmol/l

0.83

450

2700

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

383

2206

1.80

24.20

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

993

7217

1.47

24.00

1.9

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

749

2.36

23.92

1.9

1.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

162

684

2.42

23.69

1.8

1.4

117.3

103.2

u/ml

1.56

148

(3042733) HLA Ab [Presence] in Serum

114

4.69

23.08

5.4

5.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

314

1727

1.87

23.01

4.1

2.5

0.2

0.3

e6/l

0.06

305

1670

(3017446) Testosterone [Moles/volume] in Serum or Plasma

419

2520

1.72

22.76

2.4

2.1

11.9

13.4

nmol/l

2.70

377

2220

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

332

1871

1.83

22.52

8.6

7.5

24.3

24.7

mmol/l

1.24

332

1860

(3021601) Nitrite [Presence] in Urine by Test strip

2297

19394

1.35

22.50

5.8

4.5

0.0

estimate

0.80

414

3573

(3009261) Glucose [Presence] in Urine by Test strip

2316

19597

1.35

22.27

4.3

3.4

0.0

estimate

1.82

398

3451

(3000494) Fungus identified in Specimen by Culture

656

4437

1.55

22.21

1.6

1.4

—

(3016502) Oxygen saturation in Arterial blood

499

3164

1.64

22.18

7.6

96.3

95.4

2.41

481

3048

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

4032

37285

1.47

21.95

15.9

9.9

82.3

84.7

ml/min/173m2

8.74

3364

30014

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

285

1546

1.90

21.79

9.2

9.4

24.3

mmol/l

0.10

272

1431

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

3499

31583

1.38

21.71

4.5

3.9

14.7

14.6

pmol/l

0.84

3253

29006

(46235355) HIV 1 and 2 tests - Meaningful Use set

1167

8881

1.41

21.69

2.3

1.9

—

(3005719) IgG [Mass/volume] in Serum or Plasma

438

2712

1.68

21.33

2.9

2.3

10.6

10.7

g/l

0.27

412

2481

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3173

28259

1.35

21.07

3.4

3.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

741

5203

1.50

20.99

1.9

1.7

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

168

761

2.25

20.93

1.6

1.2

296.4

258.7

u/ml

0.71

110

489

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

240

1246

1.97

20.91

2.0

1.7

1.2

g/l

0.59

232

1165

(3035350) Ketones [Presence] in Urine by Test strip

2279

19351

1.33

20.89

4.3

3.3

0.0

estimate

1.08

401

3475

(3027945) Reticulocytes/100 erythrocytes in Blood

552

3644

1.58

20.72

3.4

2.3

1.7

0.59

506

3192

(3003338) MCHC [Mass/volume]

3852

35423

1.41

20.71

22.4

14.2

332.6

332.9

g/l

1.72

3837

35167

(3024354) Oxygen [Partial pressure] in Venous blood

417

2578

1.68

20.40

4.5

3.1

4.8

4.6

kpa

1.36

399

2488

(3036481) Cortisol [Moles/volume] in Serum or Plasma

529

3475

1.59

20.26

3.6

1.8

368.5

368.0

nmol/l

0.02

493

3177

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

173

807

2.19

20.07

1.6

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

250

1358

1.89

19.04

1.6

1.2

—

(3049717) Cytology report of Urine Cyto stain

194

967

2.05

18.96

2.4

1.8

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1254

9847

1.37

18.87

3.7

2.3

4876.9

4476.4

umol/l

0.12

1141

8592

(3022145) Colonoscopy Study observation

566

3847

1.53

18.57

1.4

1.3

—

(40768446) Kidney Pathology biopsy report

149

3.79

18.54

2.2

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

215

1122

1.96

18.47

2.8

2.1

94.0

93.0

0.25

202

1042

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1827

15226

1.32

18.27

2.0

1.9

95.2

96.5

pmol/l

0.64

978

7996

(3020630) Protein [Mass/volume] in Serum or Plasma

399

2511

1.64

18.18

2.7

1.6

66.5

67.2

g/l

1.26

372

2269

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1194

9365

1.36

17.95

2.4

2.2

2.7

2.8

mg/l

0.28

1044

7981

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

+∞

17.71

1.0

0.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

198

1023

1.97

17.52

3.4

2.3

188.3

176.1

1.03

188

973

(3004809) Band form neutrophils/100 leukocytes in Blood

100

389

2.60

17.47

3.1

2.8

1.1

1.2

0.13

286

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

112

461

2.46

17.40

1.6

1.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1101

8586

1.36

17.03

2.0

1.7

1.1

1.0

mg/l

0.52

813

6392

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1387

11229

1.33

16.65

2.4

2.1

171.0

221.4

u/l

1.77

1307

10561

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

211

3.16

16.53

2.4

869.9

807.6

e6/l

0.23

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

104

424

2.48

16.51

1.2

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

226

1247

1.85

16.41

1.4

1.3

11.0

9.4

u/l

0.87

185

1021

(3009542) Hematocrit [Volume Fraction] of Blood

4025

37727

1.38

15.79

19.0

12.0

39.8

40.2

1.94

3038

28286

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

108

458

2.39

15.76

2.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

331

2060

1.65

15.74

3.8

3.1

126.3

132.2

g/l

4.81

322

1995

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

265

1561

1.74

15.47

1.4

1.3

259.3

226.0

miu/ml

0.71

138

745

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

150

3.49

15.35

3.5

2.7

39.4

45.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

191

1021

1.91

15.32

3.4

2.4

3.6

3.5

g/l

0.38

180

966

(3011397) Hemoglobin [Presence] in Urine by Test strip

1140

9078

1.33

15.09

4.0

3.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

140

676

2.10

14.96

1.6

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

400

2638

1.56

14.95

3.2

2.2

67.0

69.8

e9/l

0.84

284

1977

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

121

553

2.22

14.86

2.1

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1173

9398

1.33

14.85

3.1

3.0

1458.4

1296.5

ng/l

0.54

1024

7934

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

844

6435

1.38

14.80

3.4

2.6

0.8

0.7

ug/l

0.84

604

4158

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

137

666

2.09

14.39

1.6

1.4

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

379

2.45

14.34

1.7

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

202

1125

1.83

14.27

1.2

—

(3036489) Thrombin time

234

1367

1.75

14.08

2.7

1.9

21.3

21.1

0.25

203

1154

(3028026) IgM [Mass/volume] in Serum or Plasma

329

2107

1.60

13.94

2.1

1.6

1.3

1.2

g/l

0.67

310

1942

(3017181) Myelocytes/100 leukocytes in Blood

427

2901

1.52

13.92

5.0

4.0

0.9

0.7

0.74

127

579

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

10.74

13.75

4.3

2.4

—

(3024928) Oxygen saturation in Venous blood

144

728

2.01

13.62

3.4

3.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

1035

8239

1.33

13.53

1.6

1.5

22.1

20.4

nmol/l

1.94

919

7081

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

368

2440

1.55

13.42

3.8

3.1

4.4

4.5

pmol/l

2.66

347

2171

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

195

3.00

13.40

2.0

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

198

1118

1.80

13.39

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

159

841

1.92

13.21

1.3

1.2

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

427

2934

1.50

13.18

3.1

2.2

61.5

70.1

ml/min/173m2

3.47

184

1094

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

196

1109

1.80

13.17

1.2

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

396

2683

1.52

13.07

4.4

3.8

0.4

0.5

0.10

444

(3021440) Promyelocytes/100 leukocytes in Blood

410

2800

1.51

13.03

5.1

4.1

0.1

0.48

121

539

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

294

2.58

13.00

1.7

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1132

9175

1.30

12.91

4.7

3.6

22.8

24.0

1.85

572

4166

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

914

7195

1.33

12.84

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

331

2165

1.57

12.82

1.5

1.3

24.9

26.5

iu/l

0.38

291

1859

(44806118)

351

2.42

12.74

1.8

1.4

—

(44790047)

351

2.42

12.74

1.8

1.4

—

(44790049)

351

2.42

12.74

1.8

1.4

—

(44790048)

351

2.42

12.74

1.8

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

376

2.37

12.70

1.6

1.4

—

(3003694) ABO and Rh group [Type] in Blood

1341

11136

1.28

12.63

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

4264

40646

1.39

12.60

5.2

4.6

2.7

2.8

mmol/l

4.41

4022

37887

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

203

1182

1.75

12.39

3.0

2.3

450.7

695.7

ug/l

0.55

189

1102

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

4206

40047

1.36

12.16

4.7

4.2

4.6

4.7

mmol/l

4.33

3998

37554

(40768797) Stomach Pathology biopsy report

677

5135

1.37

12.08

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

4088

38766

1.33

12.08

4.8

4.2

5.8

5.9

mmol/l

1.65

3833

35715

(3052851) Hemolysis interference index of Serum or Plasma

176

997

1.79

11.82

3.2

3.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

476

3414

1.44

11.77

3.0

2.9

—

(3045142) Bone marrow Pathology biopsy report

227

2.71

11.76

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1359

11398

1.27

11.62

5.5

3.7

3.0

2.2

ug/l

0.63

1238

10238

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

123

625

1.99

11.53

1.8

1.5

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

5.25

11.52

3.2

3.0

—

20.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

4177

39798

1.34

11.45

4.6

4.2

1.5

mmol/l

1.21

3940

37140

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

244

1544

1.61

10.90

3.2

2.7

0.7

0.07

234

1467

(3025159) Blasts/100 leukocytes in Blood

385

2699

1.46

10.74

5.2

4.1

0.0

0.2

0.59

474

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

130

691

1.91

10.72

4.0

3.7

55.5

56.9

0.60

130

691

(1761482) Bacteria [#/volume] in Urine by Culture

148

821

1.83

10.68

4.7

3.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1222

1.67

10.53

2.1

1.4

3.7

3.8

g/l

0.69

146

876

(3025941) Bacteria identified in Stool by Culture

330

2254

1.50

10.49

1.3

1.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1224

1.67

10.46

2.1

1.4

7.2

7.4

g/l

0.90

147

917

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

201

1224

1.67

10.46

2.1

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2966

27246

1.23

10.45

3.4

2.9

41.4

41.7

u/l

0.10

2809

25538

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

3.70

10.39

4.8

2.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

249

2.51

10.31

1.2

—

(40768806) Pleura Pathology biopsy report

197

2.71

10.28

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

18.80

10.25

1.1

—

(40768441) Liver Pathology biopsy report

188

2.73

10.06

1.7

1.4

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

5.02

10.03

14.7

9.5

5.5

6.0

mmol/l

0.25

(3004588) Protein electrophoresis panel - Serum or Plasma

312

2129

1.50

9.97

2.2

1.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

209

1305

1.63

9.88

4.4

5.0

1.7

0.05

196

1220

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

198

1220

1.65

9.87

2.1

1.7

0.2

g/l

0.35

190

1145

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

4035

38434

1.29

9.81

4.2

3.8

1.2

1.3

mmol/l

4.57

3790

35655

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1228

10360

1.25

9.67

1.7

1.6

1.4

mmol/l

0.30

1071

8782

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1029

8522

1.26

9.50

1.6

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

185

1132

1.66

9.49

2.1

1.4

9.9

10.4

g/l

0.91

162

959

(3024471) HLA-A [Type]

105

3.25

9.15

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

203

1293

1.59

8.88

4.4

5.1

0.9

0.01

192

1213

(3048689) Calprotectin [Mass/mass] in Stool

662

5227

1.31

8.86

2.6

2.4

116.7

120.5

ug/g

0.10

516

4124

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

190

2.59

8.81

2.4

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

158

948

1.69

8.76

2.9

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

238

1583

1.53

8.62

5.0

3.1

24.8

25.1

mmol/l

0.79

227

1516

(3024932) HLA-DR beta [Type]

104

3.19

8.61

1.0

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

291

2.25

8.56

1.5

1.6

33.8

29.6

g/l

1.52

253

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

119

664

1.81

8.51

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

119

664

1.81

8.51

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

324

2.18

8.50

1.6

1.4

—

(40765096) Chromosome analysis panel by Banding

4.46

8.35

1.2

1.0

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

153

923

1.68

8.33

2.1

1.4

0.0

g/l

0.45

144

850

(3045788) Cell count panel - Pleural fluid

208

2.47

8.28

1.5

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

182

1150

1.61

8.26

2.2

1.4

2.9

3.0

g/l

1.03

146

898

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

112

620

1.83

8.23

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

14.48

8.19

3.2

3.9

—

(3023199) Leukocytes [#/volume] in Pleural fluid

265

2.28

8.17

1.5

1.6

1021.8

2547.8

e6/l

1.94

194

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

304

2.19

8.13

3.3

4.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

166

1030

1.63

8.11

2.4

1.5

0.6

0.5

g/l

0.30

146

896

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

372

2.06

8.02

5.9

6.8

10.7

11.6

mg/l

1.00

345

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

287

2.21

7.98

1.6

1.5

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1712

15171

1.20

7.95

4.5

3.4

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

180

1147

1.59

7.90

1.1

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3814

36335

1.23

7.79

6.1

5.4

38.9

39.2

mmol/mol

1.95

3604

33934

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

146

888

1.66

7.73

2.8

1.6

32.1

41.1

mg/l

0.66

117

711

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

360

2651

1.39

7.66

6.0

2.9

1.2

mmol/l

0.01

316

2246

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

379

2817

1.37

7.62

3.4

2.9

182.8

184.7

ng/l

0.04

349

2565

(3005322) IgE [Units/volume] in Serum or Plasma

371

2750

1.38

7.59

1.3

166.2

224.6

u/ml

0.60

352

2553

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

8.35

7.58

5.4

5.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

105

588

1.80

7.47

1.2

—

(3037121) Protein [Mass/volume] in Urine

176

1132

1.58

7.45

5.2

2.6

0.3

0.4

g/l

0.47

109

411

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

139

845

1.66

7.39

2.1

1.4

0.0

g/l

0.00

131

784

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.13

7.39

2.0

1.2

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

13.36

7.37

3.0

3.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

963

8119

1.23

7.37

1.6

1.3

2.3

2.4

g/l

0.42

608

4995

(3034860) Kappa light chains.free [Mass/volume] in Serum

145

892

1.64

7.37

2.8

1.6

66.7

46.8

mg/l

1.07

115

720

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

140

856

1.65

7.29

2.1

1.4

0.0

g/l

0.50

131

786

(3047181) Lactate [Moles/volume] in Blood

160

1016

1.59

7.16

5.0

6.0

1.1

1.3

mmol/l

1.27

135

890

(3008152) Bicarbonate [Moles/volume] in Arterial blood

283

2026

1.42

7.11

6.6

7.0

24.7

24.4

mmol/l

0.62

267

1881

(3011412) CD3 cells [#/volume] in Blood

270

2.16

7.02

2.2

2.3

1.1

1.2

e9/l

0.43

139

(3019060) Gas panel - Arterial blood

290

2095

1.41

6.93

4.5

4.9

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

529

1.81

6.91

1.6

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

183

1209

1.53

6.90

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

114

670

1.72

6.90

6.4

2.7

—

(21494890) Protein electrophoresis panel - 24 hour Urine

272

2.15

6.89

1.4

1.2

—

(40761535) Cells panel - Urine sediment

396

3011

1.34

6.89

5.0

3.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

641

1.73

6.87

1.4

0.4

0.5

nmol/l

0.15

532

(3028308) Erythrocytes [#/volume] in Pleural fluid

235

2.23

6.77

1.5

1.6

78513.5

71710.0

e6/l

0.04

146

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

473

3702

1.31

6.73

2.2

1.9

—

(3011985) Renin [Units/volume] in Plasma

483

1.84

6.72

1.5

26.8

63.7

mu/l

3.85

431

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

138

860

1.62

6.70

2.8

1.5

1.1

2.7

ratio

—

(3051611) Lipemic interference index of Serum or Plasma

302

2.07

6.69

3.8

3.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

231

1612

1.45

6.68

1.6

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

202

1379

1.48

6.54

1.4

1.3

—

(3036603) Volume of Urine

202

2.29

6.43

1.6

1.5

2088.0

2207.4

—

(3051651) Icteric interference index of Serum or Plasma

171

2.41

6.43

4.5

3.7

—

(3028626) Oxygen [Partial pressure] in Capillary blood

123

754

1.65

6.39

5.6

3.2

8.9

8.4

kpa

2.26

113

704

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

150

967

1.57

6.34

2.1

1.4

38.3

38.0

g/l

0.30

137

826

(3012441) Differential panel - Pleural fluid

223

2.21

6.30

1.4

1.6

—

(3025130) Human papilloma virus identified in Specimen

104

613

1.71

6.27

1.8

1.7

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

167

1110

1.52

6.17

2.1

1.8

3.4

1.6

ug/l

0.58

150

970

(3037756) Immunofixation for Serum or Plasma

513

1.77

6.11

1.4

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

145

2.49

6.09

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

374

2875

1.33

6.06

2.4

29.7

23.3

au/ml

0.42

178

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

107

643

1.68

6.02

1.4

1.3

22.0

23.5

u/l

0.20

509

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

347

2642

1.34

6.01

1.3

66.7

49.8

au/ml

—

112

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

202

2.24

6.00

2.1

2.0

13.6

13.4

0.03

109

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

407

1.86

5.98

1.7

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

584

1.71

5.97

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

681

5658

1.24

5.91

1.4

385.4

536.4

titre

2.11

134

1178

(3029937) Albumin [Presence] in Urine by Test strip

1190

10444

1.18

5.81

4.9

3.7

0.0

estimate

0.45

398

3494

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

455

1.79

5.79

1.3

1.4

331.6

292.3

pmol/l

0.67

340

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

102

2.76

5.78

3.3

2.1

350.0

2913.7

u/ml

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

110

674

1.65

5.77

1.2

3.4

3.8

ug/l

0.33

629

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

143

2.46

5.76

3.7

1.7

142.8

163.4

0.67

134

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

443

1.80

5.69

1.1

—

69.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

257

1886

1.38

5.65

2.5

2.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.76

5.62

2.4

1.2

—

(3019150) Specific gravity of Urine by Refractometry

1001

8680

1.19

5.59

4.6

3.7

1.0

kg/l

1.02

118

1295

(3003327) Ova and parasites identified in Stool by Light microscopy

199

1401

1.44

5.55

1.6

1.8

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1092

9554

1.18

5.49

1.3

1.2

1.9

u/ml

1.64

301

2659

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.96

5.43

3.2

1.6

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

376

2944

1.30

5.36

2.1

1.8

—

(3013512) EKG study

1152

10145

1.18

5.34

3.9

3.6

—

(3039000) Anion gap in Blood

109

681

1.61

5.32

6.1

7.3

11.2

11.5

mmol/l

0.39

608

(3018572) Chloride [Moles/volume] in Blood

109

682

1.61

5.29

6.1

7.3

105.3

105.1

mmol/l

0.15

609

(3021387) Prolactin [Units/volume] in Serum or Plasma

247

1825

1.37

5.23

1.8

1.7

301.2

297.9

mu/l

0.07

231

1629

(3009508) Creatinine [Moles/volume] in Urine

1356

12115

1.17

5.23

4.1

3.2

7.4

7.8

mmol/l

2.44

1199

10315

(3047189) Immunofixation for 24 hour Urine

108

2.60

5.21

1.3

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

138

2.40

5.20

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

456

1.74

5.20

1.1

—

1.6

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

354

1.85

5.18

2.9

2.1

28.5

83.5

u/ml

1.17

322

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

139

929

1.51

5.07

1.8

1.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

408

1.78

5.05

1.1

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

172

2.22

5.02

1.2

1.1

32.0

22.4

u/l

0.35

149

(40760888) Immunoglobulin light chains.free panel - Serum

104

653

1.61

5.00

2.7

1.5

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1205

10701

1.17

4.99

4.0

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

102

638

1.61

4.98

1.1

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

241

1790

1.36

4.96

1.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

154

2.28

4.94

1.6

1.5

73.4

73.1

0.05

147

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

148

2.31

4.92

1.6

1.5

2972.1

416.6

mu/l

0.46

141

(3008757) Leukocyte morphology finding [Identifier] in Blood

275

1.94

4.91

3.4

2.9

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

311

1.88

4.87

1.2

1.1

88.8

59.0

u/l

0.55

209

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

101

635

1.60

4.84

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

125

2.41

4.79

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

125

2.41

4.79

1.8

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.07

4.78

1.9

2.1

—

(3011648) Oxygen content in Venous blood

264

1.94

4.76

2.8

2.5

11.2

0.01

264

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

357

1.80

4.76

1.2

1.1

44.4

36.7

mg/l

0.85

292

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

258

1950

1.34

4.75

1.6

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

372

1.78

4.74

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

343

1.82

4.73

1.1

269.5

241.2

mg/l

0.71

298

(4034850)

1363

0.62

4.72

11.7

8.8

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

217

2.04

4.70

2.2

505.3

464.7

e6/l

0.25

178

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

146

1003

1.47

4.69

1.8

2.1

10.4

10.5

mg/l

0.06

137

931

(3000570) Elastase.pancreatic [Mass/mass] in Stool

140

958

1.47

4.59

1.4

276.9

303.1

ug/g

0.78

526

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.02

4.57

5.7

5.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

220

1635

1.36

4.54

1.7

2.0

38.1

38.9

u/l

0.26

193

1464

(3021901) Oxygen saturation in Capillary blood

585

1.60

4.48

4.3

2.7

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

181

2.11

4.47

1.2

1.1

83.4

85.3

u/l

0.05

158

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

205

1511

1.37

4.46

1.5

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1507

13704

1.14

4.42

3.5

3.3

81.4

61.9

ng/l

0.18

937

8488

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

479

1.66

4.40

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1281

11521

1.15

4.40

5.1

4.0

11.9

9.2

mg/mmol

0.94

875

7370

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

588

1.59

4.39

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

2.62

4.39

2.4

1.8

80.0

168.8

e6/l

2.17

(3026389) Candida sp identified in Specimen by Organism specific culture

557

1.61

4.38

1.3

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

146

1018

1.45

4.37

1.2

506.7

472.3

mg/l

0.31

134

953

(1616796) Gas panel - Central venous blood

111

734

1.52

4.31

5.3

3.4

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

8.90

4.27

2.8

4.8

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

342

2730

1.27

4.24

1.2

—

(3012516) Albumin [Mass/volume] in Urine

1220

10964

1.15

4.21

4.2

3.3

426.8

292.5

mg/l

0.47

826

6971

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

159

2.15

4.20

1.2

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

106

701

1.52

4.13

2.8

2.1

6.6

4.8

umol/l

1.07

505

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

316

1.78

4.06

1.2

1.3

275.0

99.1

titre

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

316

1.78

4.06

1.2

1.3

256.3

200.4

titre

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

274

2139

1.30

4.06

2.3

2.1

3966.1

5698.9

u/l

0.47

120

879

(3009445) Proteinase 3 Ab [Units/volume] in Serum

214

1614

1.34

4.05

1.9

1.6

7.6

14.1

u/ml

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

179

1313

1.38

4.04

1.7

1.6

17.5

0.2

iu/ml

0.48

270

(3044290) Cell count panel - Cerebral spinal fluid

119

812

1.48

4.01

1.2

1.3

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

438

1.65

4.00

1.4

1.2

—

(3016038) Potassium [Moles/volume] in Urine

217

1.94

4.00

1.1

1.2

29.3

35.4

mmol/l

0.84

191

(4027681)

274

1.83

3.99

1.4

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

286

2252

1.29

3.97

1.3

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

163

2.09

3.97

1.2

1.3

—

(21494755) Public health laboratory ask at order entry panel

380

4630

0.81

3.96

1.3

—

(3000330) Specific gravity of Urine by Test strip

236

1812

1.32

3.95

4.8

3.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

262

1.84

3.89

2.2

2.7

63.4

57.7

0.85

159

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

129

901

1.44

3.87

1.2

3.7

3.8

mmol/l

0.37

116

834

(3006922) Hepatitis E virus Ab [Presence] in Serum

263

1.83

3.85

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

243

1.86

3.78

1.5

1.3

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

243

1.86

3.78

1.5

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

243

1.86

3.78

1.5

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

153

2.10

3.77

1.3

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

127

2.21

3.76

1.3

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

127

2.21

3.76

1.3

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

127

2.21

3.76

1.3

1.4

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

127

2.21

3.76

1.3

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

621

5345

1.19

3.72

1.9

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

334

1.71

3.67

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

155

2.07

3.66

1.2

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

120

838

1.44

3.62

4.6

3.2

23.7

24.8

mmol/l

2.03

105

741

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

3.43

3.61

1.3

1.7

—

(3045414) Leukocytes [Presence] in Urine

228

1768

1.30

3.59

1.9

1.8

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

371

3051

1.23

3.58

2.6

2.3

11.7

7.7

ug/l

0.93

337

2679

(3023410) Appearance of Cerebral spinal fluid

383

1.65

3.55

1.3

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

144

1045

1.39

3.52

1.4

1.2

45.5

139.2

titre

1.09

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.85

3.52

1.5

1.3

—

(3012501) Base excess in Blood by calculation

105

721

1.47

3.48

5.2

3.9

2.4

mmol/l

0.05

450

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

390

4665

0.82

3.41

4.7

4.3

33.1

32.2

0.98

284

3249

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

245

1.80

3.39

1.1

1.0

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

358

1.66

3.37

2.5

2.1

—

(3020891) Body temperature

176

1330

1.34

3.35

5.1

4.7

—

(3036525) Urea [Moles/time] in 24 hour Urine

5.72

3.34

2.3

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

109

761

1.44

3.33

1.2

1.3

—

(3041806) Other cells [#/volume] in Blood by Manual count

189

1.91

3.33

1.4

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

2.37

3.31

1.7

2.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

2.92

3.29

1.1

1.4

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

197

1.88

3.28

1.1

—

(3000492) Spirometry study

460

3901

1.20

3.27

1.6

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

124

890

1.40

3.26

1.3

1.4

730.5

1169.4

e6/l

0.26

743

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

308

1.70

3.26

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

2.78

3.25

3.6

1.3

91.9

93.2

ng/l

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

124

891

1.40

3.24

1.2

1.3

6.5

21.4

e6/l

1.40

703

(3016750) Collection duration of Urine

213

1.84

3.21

3.1

2.2

502.9

494.5

min

0.21

162

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

402

1.60

3.20

1.2

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

5.34

3.19

3.4

3.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

519

4460

1.18

3.19

28.1

24.5

1.3

inr

0.07

667

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

243

1.78

3.18

1.1

1.0

—

(3000093) Morphology [Interpretation] in Blood Narrative

303

1.69

3.17

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

605

1.48

3.13

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

201

1.85

3.11

1.2

1.1

1665.0

1443.5

miu/ml

0.57

201

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

105

739

1.43

3.10

1.5

1.4

111.7

56.3

pmol/l

0.94

105

719

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.08

2.2

2.8

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

138

1019

1.36

3.08

1.2

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

617

1.47

3.05

1.2

1.1

112.7

115.0

0.26

559

(40767503) Oxygen content in Capillary blood by calculation

685

1.44

3.01

3.3

2.4

16.8

0.04

356

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

365

3055

1.21

3.01

1.2

133.7

152.2

iu/ml

0.36

123

1202

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

378

1.59

2.99

1.3

—

(3003181) Sodium [Moles/volume] in Urine

531

1.50

2.96

1.2

1.4

74.5

64.8

mmol/l

1.27

429

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.24

2.96

1.2

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

3.15

2.93

7.2

3.7

29.3

36.9

g/mol

0.14

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.83

2.91

1.1

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

184

1.85

2.91

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.22

2.89

1.2

1.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.22

2.89

1.2

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.22

2.89

1.2

1.5

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

2.70

2.88

10.5

1.3

75.7

111.9

u/l

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

102

2.16

2.86

1.3

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.29

2.83

1.2

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.77

2.81

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.06

2.80

2.9

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

530

4613

1.17

2.80

8.2

6.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

216

1.77

2.79

1.4

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.45

2.79

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

740

6601

1.14

2.79

1.7

1146.3

1161.2

nmol/l

0.16

587

5025

(4010399)

328

2745

1.21

2.73

1.5

1.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.24

2.70

1.2

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

279

1.65

2.70

1.1

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

4.22

2.67

1.1

1.7

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.28

2.67

1.4

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

288

1.64

2.65

3.1

2.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

153

1178

1.31

2.63

1.7

42.2

41.9

nmol/l

0.04

153

1139

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.39

2.63

2.1

1.5

106.7

143.6

ng/l

0.61

(3013005) Retinol [Moles/volume] in Serum or Plasma

155

1.88

2.60

2.2

2.0

2.1

1.9

umol/l

0.42

144

(21494434) Karyotype in Bone marrow

221

1.73

2.60

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

457

1.49

2.59

1.4

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

369

1.55

2.58

1.1

—

(40761536) Microorganisms panel - Urine sediment

384

3281

1.18

2.56

4.8

3.5

—

(40757373) Influenza virus identified in Isolate

2.42

2.53

2.6

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

395

1.53

2.53

1.1

1.3

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.27

2.50

1.2

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

131

997

1.32

2.46

4.2

4.3

3.9

mmol/l

0.26

125

934

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

102

2.06

2.46

1.3

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

123

1.96

2.44

1.5

—

(3028433) Virus identified in Specimen by Culture

123

1.96

2.44

1.3

1.1

—

(3004775) Volume in Urine collected for unspecified duration

303

1.59

2.43

3.0

2.3

760.5

628.5

1.25

207

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.09

2.42

1.2

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

104

2.02

2.35

1.2

1.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

2.15

2.34

1.3

1.2

251.8

261.3

pmol/l

0.07

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

619

1.40

2.32

1.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

125

955

1.32

2.31

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

3.22

2.30

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

126

1.91

2.30

1.5

7.9

8.5

ug/l

0.59

126

(3024980) IgG subclass 4 [Mass/volume] in Serum

663

1.38

2.29

1.5

1.6

0.5

0.8

g/l

2.58

512

(3019768) Coxiella burnetii Ab [Presence] in Serum

3.48

2.27

1.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

648

1.38

2.26

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

3.89

2.25

1.1

1.8

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

106

1.99

2.25

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

604

0.63

2.22

3.9

5.2

369.0

367.5

umol/l

0.02

519

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

133

1032

1.30

2.21

1.8

2.0

4.5

4.2

iu/l

0.13

398

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

121

1.91

2.20

1.2

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

121

1.91

2.20

1.2

1.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

195

1.70

2.18

1.1

—

(3045424) Erythrocytes [Presence] in Urine

645

1.37

2.16

1.5

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.00

2.14

2.1

1.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

104

784

1.33

2.13

2.7

2.1

130.1

132.9

g/l

0.54

582

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

259

1.59

2.11

1.5

1.6

18.7

23.8

u/ml

—

(3025549) Creatine [Moles/time] in 24 hour Urine

3.20

2.09

1.3

1.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

160

1.75

2.09

1.1

1.4

—

(3017732) Neutrophils [#/volume] in Blood

317

2718

1.18

2.08

2.4

2.5

4.3

4.1

e9/l

0.53

259

2127

(3017704) Immunofixation for Urine

153

1.77

2.07

1.2

—

(3010421) pH of Blood

113

867

1.31

2.06

5.6

3.9

7.4

0.57

105

712

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

333

1.51

2.05

1.7

1.3

—

titre

—

(3025315) Body weight

3.08

2.01

7.3

3.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

275

2343

1.18

1.96

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

120

1526

0.78

1.95

1.5

2.2

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.03

1.95

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

207

1720

1.21

1.94

1.3

1.2

1.6

1.0

u/ml

0.19

153

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

413

1.43

1.91

1.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.05

1.90

1.2

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.92

1.90

10.4

7.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

275

1.53

1.89

1.8

1.2

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

1.82

1.88

1.0

1.1

85.9

93.9

0.42

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

121

1.82

1.88

2.7

2.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

415

1.43

1.87

1.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

268

1.53

1.86

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

129

1.79

1.85

1.0

1.1

83.5

93.1

0.70

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.50

1.83

1.6

2.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

510

1.38

1.83

1.3

65.1

38.2

u/ml

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

557

5020

1.12

1.83

1.8

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

137

1.76

1.83

1.1

1.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

207

1.60

1.79

1.2

1.5

—

(3008295) Osmolality of Serum or Plasma

328

1.47

1.78

1.6

1.5

282.7

280.3

mosm/kgh2o

0.40

253

(3011288) Drugs identified in Urine by Screen method

105

1339

0.78

1.78

2.1

3.0

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

337

1.46

1.76

1.0

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.94

1.74

3.1

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.94

1.74

6.2

6.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

405

1.41

1.73

1.3

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.85

1.71

8.0

4.7

333.8

385.7

umol/l

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

140

1.72

1.71

1.3

1.2

111.1

109.3

0.15

121

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

423

1.40

1.71

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

407

1.41

1.69

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

648

1.32

1.68

1.3

1.4

3.5

u/ml

2.68

213

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

631

1.32

1.67

1.3

5.1

4.9

u/ml

0.04

271

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.80

1.65

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

410

1.39

1.64

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.25

1.63

1.2

—

(3005033) Fetal Nuchal fold Thickness US

147

1207

1.22

1.60

1.3

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

262

1.49

1.60

1.1

0.6

7.9

nmol/l

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.33

1.60

1.9

1.5

17.0

21.5

pmol/l

—

(3050794) Legionella sp Ab [Presence] in Serum

2.50

1.59

1.4

1.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.50

1.59

1.5

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

110

878

1.26

1.55

1.3

1.2

53.9

45.1

u/ml

0.22

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.85

1.55

1.1

—

(1002224) Polysomnography panel

210

1790

1.18

1.55

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

147

1212

1.22

1.55

1.3

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

527

1.33

1.53

3.3

3.0

0.8

nmol/l

0.24

400

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

101

800

1.27

1.53

1.7

1.9

184.5

198.4

pmol/l

0.64

749

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

257

1.48

1.52

1.2

1.1

12.1

10.6

iu/ml

0.08

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.34

1.52

1.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.86

1.50

1.5

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.16

1.50

1.3

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.50

1.45

1.1

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

140

1.65

1.44

1.1

1.5

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

244

1.48

1.44

1.3

1.5

5.9

6.2

u/l

0.18

214

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

3.13

1.44

1.2

1.0

—

(3009343) pH of Capillary blood

245

2131

1.16

1.43

5.9

3.5

7.4

0.18

255

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

248

2160

1.16

1.42

6.0

3.5

5.0

5.2

kpa

3.01

228

2002

(3043238) Trisomy 21 risk [Likelihood] in Fetus

149

1245

1.20

1.40

1.4

1.5

—

(4306422)

651

1.28

1.38

1.3

1.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

142

1.62

1.38

1.1

1.5

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.00

1.38

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.00

1.38

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.00

1.38

1.0

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.20

1.37

2.4

2.6

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

2.94

1.36

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

2.14

1.33

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

371

4118

0.89

1.33

1.6

1.7

—

(4024509)

369

0.65

1.32

1.3

1.5

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

428

1.34

1.31

1.3

—

38.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

284

1.41

1.29

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

301

1.40

1.29

1.4

1.3

27.2

32.5

nmol/l

0.63

273

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.78

1.28

1.2

2.7

—

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

2.78

1.28

7.8

12.3

75.2

197.0

e6/l

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

324

2897

1.13

1.28

1.5

—

(4062490)

430

1.33

1.28

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

154

1811

0.85

1.27

1.7

2.2

—

(3042631) Mycobacterium sp identified in Specimen

353

1.36

1.27

3.6

3.3

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

1.79

1.27

1.1

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

211

1.47

1.25

1.9

1.7

—

(4268621)

432

1.32

1.24

2.4

2.3

—

(3014891) Appearance of Pleural fluid

2.22

1.24

2.6

1.4

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

235

2064

1.15

1.23

6.0

3.4

1.1

1.6

mmol/l

1.50

159

1498

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

516

4744

1.10

1.23

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

174

1495

1.17

1.22

1.3

1.4

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

2.63

1.21

1.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

174

1498

1.17

1.20

1.3

1.4

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

719

1.24

1.20

1.2

—

(3044941) Cell count panel - Synovial fluid

603

1.26

1.19

1.3

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

174

1499

1.17

1.19

1.3

1.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.83

1.19

1.3

1.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.31

1.18

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

281

1.39

1.18

1.2

—

(3027944) Amphetamines [Presence] in Urine

167

1936

0.86

1.17

1.7

2.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

173

1493

1.16

1.3

1.4

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

198

1.47

1.16

11.1

5.9

52.4

187.0

u/ml

—

(3023383) Lactate [Moles/volume] in Pleural fluid

2.00

1.16

1.3

1.4

3.2

2.9

mmol/l

—

(3028300) Cannabinoids [Presence] in Urine

171

1973

0.86

1.14

1.7

2.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

283

1.38

1.14

1.2

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

241

1.41

1.13

1.4

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

489

5301

0.91

1.13

1.8

1.7

1.4

0.67

446

4703

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.35

1.12

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

327

1.35

1.12

1.2

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

163

1406

1.16

1.12

1.6

—

(3004451) EKG impression Narrative

151

1.53

1.11

1.3

1.2

—

(3000764) Benzodiazepines [Presence] in Urine

170

1957

0.86

1.11

1.7

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

285

1.37

1.10

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

328

1.34

1.10

1.2

1.1

—

(3027008) Opiates [Presence] in Urine

171

1966

0.87

1.10

1.7

2.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

186

1624

1.15

1.09

1.3

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

692

1.23

1.09

4.0

2.7

30.8

34.6

umol/l

0.94

602

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.38

1.09

1.6

1.0

—

(3009871) Measles virus Ab [Titer] in Serum

136

1.55

1.08

1.6

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

390

1.31

1.08

1.3

1.4

10.9

11.7

mmol/l

0.27

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.69

1.07

12.6

7.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

324

1.33

1.02

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

324

1.33

1.02

1.2

1.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

790

1.21

1.01

4.8

2.0

0.8

nmol/l

0.49

666

(3024139) IgG subclass 3 [Mass/volume] in Serum

430

1.28

1.01

1.2

1.4

0.3

0.4

g/l

0.56

308

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

325

1.33

1.00

1.2

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

111

938

1.19

1.00

3.1

2.4

162.7

104.3

ug/min

0.65

573

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

282

1.35

1.00

1.1

1.2

1.1

ratio

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.62

0.99

1.8

2.7

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

431

1.28

0.99

1.2

1.4

3.0

2.9

g/l

0.01

309

(3027135) IgG subclass 1 [Mass/volume] in Serum

431

1.28

0.99

1.2

1.4

6.0

6.6

g/l

1.33

309

(4038314)

2.18

0.98

1.0

1.2

—

(3003577) Lead [Moles/volume] in Blood

0.00

0.97

0.0

1.2

—

0.1

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.95

0.97

1.3

1.2

—

(3017509) Phencyclidine [Presence] in Urine

1.85

0.96

1.4

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.74

0.96

1.9

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

740

1.21

0.96

1.7

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

253

2807

0.90

0.96

1.4

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.95

0.0

1.0

—

0.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

217

1.38

0.93

2.1

1.9

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

608

1.22

0.91

1.2

1.5

—

(3035880) pH of Pleural fluid

118

1.53

0.90

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

177

1566

1.14

0.90

1.8

1.6

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

193

1.40

0.90

1.6

1.5

14.3

5.6

u/l

0.30

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

314

1.31

0.89

1.1

1.2

2.1

2.0

mmol/l

0.31

291

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

546

1.23

0.89

1.2

23.7

26.6

u/l

0.16

472

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

101

0.49

0.89

1.0

1.2

—

(3044007) Cell count panel - Peritoneal fluid

1.69

0.88

1.5

2.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

672

0.80

0.87

1.3

1.4

6.6

7.2

mmol/l

0.74

493

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

204

1.37

0.85

1.0

1.1

90.3

91.7

0.08

163

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.94

0.84

1.2

—

(3037556) Urate [Mass/volume] in Serum or Plasma

112

0.54

0.83

1.3

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

134

1172

1.15

0.82

1.3

1.2

45.5

41.4

u/ml

0.08

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.88

0.81

1.7

1.1

—

(3035320) C reactive protein [Mass/volume] in Body fluid

267

1.31

0.80

1.8

2.3

—

(4146454)

397

0.75

0.80

3.3

2.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

147

1.43

0.80

1.0

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

321

1.28

0.79

1.9

1.3

2.3

0.7

u/ml

0.92

129

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.67

0.78

1.6

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.67

0.78

1.3

1.0

—

(3014271) Vancomycin [Susceptibility]

150

0.60

0.78

2.3

2.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

225

1.34

0.78

1.1

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

505

0.79

0.76

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

256

0.70

0.75

1.3

2.8

—

(3024263) Appearance of Synovial fluid

209

1.34

0.75

2.4

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

124

1.45

0.75

1.2

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.60

0.74

1.0

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

1.84

0.73

1.6

1.5

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.00

0.72

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.58

0.71

3.2

1.5

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.58

0.71

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

220

1.32

0.71

1.1

1.2

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.58

0.71

1.6

3.1

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.71

0.70

1.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.85

0.68

1.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

338

1.24

0.67

1.2

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.79

0.66

1.2

1.5

332.2

338.0

umol/24h

—

(3044927) Protein electrophoresis panel - Urine

339

1.24

0.66

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

863

0.86

0.66

2.1

2.9

—

(3014051) Protein [Presence] in Urine by Test strip

905

0.86

0.65

2.1

2.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.59

0.65

1.6

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.59

0.65

1.4

1.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.57

0.65

1.1

1.5

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.72

0.64

1.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

146

1.37

0.63

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

112

1.43

0.63

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

103

907

1.14

0.62

1.6

14414.7

10455.4

e6/l

0.27

655

(3000034) Microalbumin [Mass/volume] in Urine

360

1.22

0.62

3.8

3.1

76.1

40.8

mg/l

0.44

271

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

832

7995

1.05

0.62

1.6

34126319.1

38499606.1

pmol/l

0.08

715

6743

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

164

1.34

0.62

1.0

1.2

—

(3033799) Differential panel - Peritoneal fluid

1.55

0.62

1.6

2.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.59

0.61

1.1

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.67

0.61

1.4

1.5

—

6.8

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

412

0.80

0.60

2.4

2.2

26.6

22.1

mg/l

—

114

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.60

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

697

1.15

0.58

1.1

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

147

1332

1.11

0.57

2.3

1.9

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

176

1.31

0.56

1.2

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

136

1229

1.11

0.56

1.1

2.2

5.2

u/ml

1.34

173

(3023511) Choriogonadotropin [Units/volume] in Urine

126

1134

1.11

0.56

1.5

1.3

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

296

0.78

0.55

24.0

18.1

1349.9

1454.3

nmol/l

0.33

288

(3030313) Adrenal Ab [Titer] in Serum

1.58

0.54

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

227

0.75

0.53

1.4

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

206

1908

1.08

0.52

1.4

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

118

1064

1.11

0.52

1.3

1.2

4.1

6.1

u/ml

0.21

103

(3044009) aPTT.lupus sensitive (LA screen)

1.50

0.51

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

586

0.85

0.51

1.0

1.1

0.0

0.3

u/ml

—

138

(4198724)

214

0.75

0.51

1.9

2.9

—

(3001019) Free T4 and TSH panel - Serum or Plasma

234

2509

0.93

0.51

1.7

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

456

0.83

0.50

1.6

6.7

7.6

mmol/l

1.98

281

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

119

1077

1.11

0.49

1.3

2.7

5.8

u/ml

1.30

170

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

291

0.79

0.49

20.2

12.6

883.3

832.7

nmol/l

0.22

277

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

156

0.70

0.49

2.3

2.4

—

(3022621) pH of Urine by Test strip

242

2588

0.93

0.49

2.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

849

1.12

0.49

1.3

1.2

5.5

u/ml

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

154

1.30

0.48

1.4

1.1

17.9

22.3

u/l

0.17

113

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

813

1.12

0.48

1.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

290

1.21

0.47

1.1

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

111

1.35

0.46

1.0

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.43

0.46

1.7

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

254

0.79

0.45

1.0

34.5

46.9

ng/l

1.16

164

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

150

1382

1.09

0.45

2.3

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

178

1652

1.08

0.45

2.1

1.9

—

(3020491) Glucose [Moles/volume] in Blood

321

1.19

0.43

1.7

1.9

6.5

6.3

mmol/l

0.18

226

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.61

0.43

1.2

1.1

6.7

11.3

mg/l

—

(3001729) Color of Synovial fluid

1.61

0.43

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

140

1.29

0.41

5.9

4.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

176

1.25

0.41

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

249

1.21

0.41

1.2

1.1

1.0

u/l

0.48

111

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

700

1.12

0.40

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.47

0.40

1.2

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

186

1.24

0.40

2.2

2.1

166.8

231.8

ug/min

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.33

0.40

1.1

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

625

1.12

0.40

1.1

1.0

2.6

2.9

u/ml

0.11

315

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.36

0.40

1.1

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

650

6289

1.04

0.39

2.5

2.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.31

0.39

1.0

1.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.31

0.39

1.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.43

0.39

1.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

447

1.14

0.38

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

124

1.29

0.38

1.2

1.1

—

(44813793)

308

1.17

0.37

1.1

—

(3022313) Gas panel - Capillary blood

167

1562

1.07

0.37

6.7

3.6

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.35

0.37

1.2

1.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

872

0.90

0.37

1.1

6.0

5.8

u/ml

0.05

459

(3039443) Prostate specific Ag panel - Serum or Plasma

667

1.11

0.37

1.5

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

134

1.27

0.36

1.2

1.1

0.2

3.5

u/ml

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

840

0.90

0.36

1.1

0.7

1.1

u/ml

0.40

356

(3023419) Bacteria identified in Sputum by Culture

432

1.14

0.35

3.0

2.8

—

(4281824)

208

1.20

0.35

1.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

126

1.27

0.35

1.0

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

147

1374

1.07

0.34

1.9

1.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

812

0.91

0.32

1.1

1.2

1.7

u/ml

0.38

204

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.35

0.32

1.4

2.2

—

(3021788) Differential panel - Synovial fluid

685

1.10

0.31

1.4

1.5

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

258

1.16

0.31

1.6

2.1

1.8

2.0

u/field

0.10

114

(3001556) Androgen free Index in Serum or Plasma

1.32

0.30

1.0

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

135

1266

1.07

0.30

2.3

1.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.33

0.30

1.9

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

291

0.86

0.28

1.2

1.1

1.0

2.5

u/ml

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.30

0.26

1.6

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

579

5652

1.03

0.24

2.4

2.0

—

(4094501)

113

1064

1.06

0.24

1.1

—

(3000012) Reticulocyte production index

170

1.18

0.24

1.3

1.4

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

971

0.94

0.23

1.1

2.9

1.4

u/ml

0.42

386

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

688

1.08

0.23

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

553

1.09

0.23

1.3

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.28

0.23

3.0

10.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

200

0.85

0.22

1.6

2.4

22.1

60.0

ug/l

0.50

187

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

172

1.16

0.22

2.6

3.2

7.0

7.5

mg/l

0.16

141

(3019174) dRVVT (LA screen)

1.22

0.22

1.2

—

(3006270) Folate [Moles/volume] in Blood

347

0.89

0.22

1.2

1.1

411.8

382.7

nmol/l

0.28

308

(36660697) Celiac disease serology panel - Serum

358

3478

1.03

0.22

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

163

1.17

0.21

1.0

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.19

0.21

3.4

2.5

1.0

0.6

u/field

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.1

—

3474.6

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.2

—

(3022670) pH of Venous cord blood

0.00

0.21

0.0

1.2

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.3

—

27.4

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

8.1

—

(3036180) Methadone [Presence] in Urine

0.00

0.21

0.0

2.1

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

22.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.2

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3020650) Glucose [Presence] in Urine

102

0.78

0.21

1.5

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.4

—

417.5

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

646

0.93

0.20

1.0

1.1

5.1

3.4

u/ml

0.31

263

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

0.00

0.20

0.0

1.1

—

0.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

282

0.89

0.20

1.4

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

307

1.11

0.20

1.3

1.4

54.7

170.8

pmol/l

0.55

(3015076) Soybean IgE Ab [Units/volume] in Serum

250

0.88

0.20

1.1

1.0

0.3

2.7

u/ml

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.20

0.19

1.0

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

269

1.12

0.19

1.8

1.6

—

68.1

—

(44806420)

1.22

0.19

2.8

2.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.13

0.18

1.0

1.3

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

280

0.89

0.18

1.4

5.3

5.6

mmol/l

0.92

269

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

116

1106

1.05

0.18

1.4

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

195

0.87

0.17

1.4

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.75

0.17

2.0

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

392

0.92

0.16

1.5

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

700

6894

1.02

0.16

1.3

13.6

11.6

u/ml

0.20

284

2793

(3051387) C reactive protein [Mass/volume] in Capillary blood

850

0.95

0.14

2.9

3.3

20.4

26.5

mg/l

1.16

529

(3035933) Granulocytes/100 leukocytes in Blood

118

0.85

0.14

1.0

1.6

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1022

0.96

0.14

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

285

1.09

0.14

1.0

—

(3008898) HLA-B27 [Presence]

160

1651

0.97

0.14

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

336

0.92

0.13

1.2

1.6

1.3

1.4

promille

0.11

262

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

199

1.11

0.13

1.3

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

736

7269

1.01

0.13

1.3

25.1

30.8

iu/ml

0.76

215

2229

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

355

1.07

0.12

1.4

36.9

30.7

0.37

224

(3015183) Erythrocyte sedimentation rate

239

1.09

0.12

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

134

1382

0.97

0.12

6.8

3.6

24.5

24.7

mmol/l

0.53

122

1282

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

183

1.09

0.10

1.5

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

697

0.96

0.09

1.1

2.0

3.3

u/ml

0.77

274

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.06

0.09

1.0

—

(3000285) Sodium [Moles/volume] in Blood

1.06

0.09

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

145

1.10

0.09

3.1

3.0

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

155

1.10

0.09

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

675

1.04

0.09

1.1

14.8

14118.9

iu/ml

0.54

166

(44816559) Phosphatidylethanol [Mass/volume] in Blood

847

0.97

0.09

1.3

—

(3017569) Oxygen content in Arterial blood

175

0.91

0.08

1.5

1.9

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

263

1.07

0.08

1.5

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.78

0.08

1.0

1.1

—

(3019225) pH of Specimen

338

3337

1.01

0.08

7.0

3.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.12

0.07

2.6

2.0

13.3

16.1

umol/l

0.72

(3005011) Chlamydia sp Ab [Titer] in Serum

0.82

0.07

2.0

1.6

—

(3006462) Nitrate [Presence] in Urine

196

1.07

0.07

2.5

2.9

—

(4015189)

0.87

0.06

6.1

2.5

—

(3013637) Mi-2 Ab [Presence] in Serum

103

0.87

0.06

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

103

0.87

0.06

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

103

0.87

0.06

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

103

0.87

0.06

1.0

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

103

0.87

0.06

1.0

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.86

0.06

1.3

2.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

105

0.86

0.06

1.3

2.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

131

1286

1.02

0.06

1.8

—

(4133840)

110

0.91

0.05

1.3

1.2

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

357

1.04

0.04

1.3

1.2

1.5

nmol/l

0.87

318

(3051593) INR in Capillary blood by Coagulation assay

160

0.94

0.04

3.3

8.7

—

(3019977) pH of Arterial blood

180

1.06

0.04

1.6

2.5

7.4

—

(3006653) Thiamine [Moles/volume] in Blood

210

1.05

0.03

1.3

1.4

128.1

136.0

nmol/l

0.41

210

(3034426) Prothrombin time (PT)

149

0.94

0.03

1.1

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

399

1.03

0.03

3.9

24.3

7.1

7.2

mmol/l

0.07

327

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

471

0.98

0.03

1.5

48.0

58.1

0.79

304

(4211845)

221

1.04

0.03

2.4

2.9

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

122

1.07

0.02

1.0

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

640

1.02

0.02

1.6

—

(1761868) Lipid panel - Serum or Plasma

1521

15190

1.00

0.02

3.1

2.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

183

1.04

0.01

1.4

1.8

—

(3022689) Creatine [Moles/volume] in Urine

125

0.96

0.00

1.9

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

348

1.01

0.00

1.3

132671.7

110120.3

e6/l

0.07

246

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

171

1712

1.00

0.00

1.5

1.7

3.1

4.0

mg/l

0.75

117

1170

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

51.3

—

(3024869) Neuronal Ab [Presence] in Serum

1.02

0.00

1.0

1.1

—

(3049233) Organic acids panel - Urine

0.00

0.0

1.0

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1273.3

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.3

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.0

1.1

—

87.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

0.90

0.00

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

200

1.00

0.00

1.0

1.1

—

(3048879) Bone marrow aspiration report

0.94

0.00

1.5

1.6

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.0

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(44806071)

0.94

0.00

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.01

0.00

7.7

7.6

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

1.9

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

1.00

0.00

6.4

6.5

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3002619) Bacteria identified in Specimen by Culture

0.95

0.00

1.9

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.0

1.3

—

70.8

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

1.8

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_MELANOCYTIC_TRUNK_EXALLC – Melanocytic naevi of trunk

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Melanocytic naevi of trunk

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints